GL Brands (GRLB) 10-K 15 Oct 18 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jun. 30, 2018	Oct. 15, 2018	Dec. 31, 2017
Document And Entity Information
Entity Registrant Name	Freedom Leaf Inc.
Entity Central Index Key	1,581,545
Document Type	10-K
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Public Float			$ 5,527,947
Entity Common Stock, Shares Outstanding		221,049,501
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,018

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Current assets
Cash	$ 54,380	$ 2,498
Accounts receivable, net	161,975	0
Inventory, net	201,689	0
Prepaid expenses and other current assets	578,864	1,600
Other receivable, net of discount	0	637,817
Due from related parties	28,606	0
Total current assets	1,025,514	641,915
Property and equipment, net	4,786,050	0
Intangible assets, net	1,522,574	10,820
Goodwill	70,000	0
Cost method investments	994,500	0
Other assets	0	338,084
Total assets	8,399,538	990,819
Current liabilities
Accounts payable and accrued expenses	557,654	47,680
Convertible notes payable, net of discount	0	70,678
Current portion of long-term notes payable	95,000	0
Short-term notes payable	286,575	3,141
Derivative liabilities	0	52,757
Total current liabilities	939,229	174,256
Non-current liabilities
Long-term notes payable, net of discounts, net of current portion	4,441,911	0
Other non-current liabilities	0	188,075
Payables to related party	0	290,670
Total non-current liabilities	4,441,911	478,745
Total liabilities	5,381,141	653,001
Commitments and contingencies	0	150,000
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized, Series A preferred stock, 1,000,000 shares authorized, 948,022 shares issued and outstanding at June 30, 2018 and 2017, respectively	948	948
Common stock, $0.001 par value, 500,000,000 shares authorized,185,369,365 and 111,101,795 shares issued, issuable, and outstanding at June 30, 2018 and 2017, respectively	185,370	111,102
Additional paid-in capital	12,377,907	4,996,756
Accumulated comprehensive income	3,833	0
Accumulated deficit	(9,540,976)	(4,920,988)
Total Freedom Leaf Inc. stockholders' equity	3,027,082	187,818
Non-controlling interest	(8,684)	0
Total stockholders' equity	3,018,398	187,818
Total liabilities and stockholders' equity	$ 8,399,538	$ 990,819

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2018	Jun. 30, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	948,022	948,022
Preferred stock, shares outstanding	948,022	948,022
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	185,369,365	111,101,795
Common stock, shares outstanding	185,369,365	111,101,795

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenue, net	$ 411,272	$ 817,457
Operating expenses
Direct costs of revenue	311,213	124,290
General and administrative	2,237,301	1,421,224
Depreciation and amortization	170,916	0
Bad debt expense	754,717	0
Marketing and selling	49,656	41,712
Total operating expenses	3,523,803	1,587,226
Operating loss	(3,112,531)	(769,769)
Other income (expense)
Interest expense	(29,105)	(47,221)
Loss on settlement of debt	(1,063,610)	0
Interest income	10,345	7,002
Licensing income - related party	240,000	0
Loss on settlement of accounts payable	(263,132)	0
Miscellaneous income	12,483	0
Loss on investment	(12,141)	0
Loss on disposal of assets	(295,400)	0
Change in fair value of embedded conversion features	(59,127)	(21,506)
Loss on foreign currency transaction adjustments	(2,355)	0
Beneficial conversion feature	(45,416)	(79,156)
Total other income (expense)	(1,507,458)	(140,881)
Provision for income taxes	0	0
Net loss before non-controlling interest	(4,619,989)	(910,650)
Loss attributable to non-controlling interest	(8,684)	0
Net loss attributable to common stockholders	$ (4,628,672)	$ (910,650)
Net loss attributable to common stockholders per share - basic and diluted	$ (0.03)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	149,199,226	100,294,433
Foreign currency translation gain	$ 3,833	$ 0
Total comprehensive loss	$ (4,624,839)	$ (910,650)

Consolidated Statement of Share

Consolidated Statement of Shareholders' Deficit - USD ($)	Preferred Stock	Common Stock Issuable	Common Stock	Unearned Stock Compensation	Additional Paid-In Capital	Noncontrolling Interest	Accumulated Comprehensive Income	Accumulated Deficit	Total
Beginning balance, shares at Jun. 30, 2016	948,022	6,149,650	88,289,000
Beginning balance, value at Jun. 30, 2016	$ 948	$ 6,150	$ 88,289	$ (170,137)	$ 3,800,699	$ 0	$ 0	$ (4,010,338)	$ (284,390)
Contributed capital					21,082				21,082
Unearned Stock Compensation				170,137					170,137
Issuance of issuable stock issued, shares		(1,285,000)	1,285,000
Issuance of issuable stock issued, value		$ (1,285)	$ 1,285
Cancellation of issuable shares, shares		(5,014,650)
Cancellation of issuable shares, value		$ (5,015)			(229,842)				(234,857)
Sale of common stock, shares			3,112,501
Sale of common stock, value			$ 3,113		146,887				150,000
Issuance of common stock for services, shares		1,943,195	11,479,477
Issuance of common stock for services, value		$ 1,943	$ 11,479		737,568				750,990
Issuance of common stock for debt, shares			1,004,701
Issuance of common stock for debt, value			$ 1,005		56,182				57,187
Vesting of fair value of warrants					72,069				72,069
Beneficial conversion feature					50,000				50,000
Issuance of common stock for conversion of debt, shares			791,140
Issuance of common stock for conversion of debt, value			$ 791		147,167				147,958
Issuance of common stock for acquisition of intellectual property, shares			3,000,000
Issuance of common stock for acquisition of intellectual property, value			$ 3,000		181,500				184,500
Issuance of common stock for settlement of debt, shares			346,781
Issuance of common stock for settlement of debt, value			$ 347		13,444				13,791
Net loss								(910,650)	(910,650)
Ending balance, shares at Jun. 30, 2017	948,022	1,793,195	109,308,600
Ending balance, value at Jun. 30, 2017	$ 948	$ 1,793	$ 109,309	0	4,996,756	0	0	(4,920,988)	187,818
Issuance of common stock for asset, shares			3,100,000
Issuance of common stock for asset, value			$ 3,100		310,260				313,360
Sale of common stock, shares			15,410,827
Sale of common stock, value			$ 15,410		973,148				851,058
Issuance of common stock and warrants for cash, shares			4,444,444
Issuance of common stock and warrants for cash, value			$ 4,444		395,556				400,000
Issuance of common stock for accounts payable, shares		(1,016,163)	14,236,438
Issuance of common stock for accounts payable, value		$ (1,016)	$ 14,236		648,223				661,443
Issuance of common stock for services, shares		(116,280)	11,610,342
Issuance of common stock for services, value		$ (114)	$ 11,610		1,190,719				1,339,715
Issuance of common stock for debt, shares			12,263,698
Issuance of common stock for debt, value			$ 12,264		1,334,255				1,346,519
Issuance of common stock for inventory and intangibles, shares			3,100,000
Issuance of common stock for inventory and intangibles, value			$ 3,100		310,260				313,360
Issuance of common stock for business combinations, shares			8,118,886
Issuance of common stock for business combinations, value			$ 8,119		1,285,904				1,294,023
Issuance of common stock in exercise of warrants, shares			215,378
Issuance of common stock om exercise of warrants, value			$ 215		(215)
Vesting of fair value of warrants					114,658				114,658
Issuance of common stock for cost method investment, shares			6,000,000
Issuance of common stock for cost method investment, value			$ 6,000		989,400				995,400
Issuance of warrants for prepaid royalties - related party					139,243				139,243
Accumulated comprehensive income							3,833		3,833
Net loss						8,684		(4,619,989)	(4,628,672)
Ending balance, shares at Jun. 30, 2018	948,022	660,752	184,708,613
Ending balance, value at Jun. 30, 2018	$ 948	$ 663	$ 184,707	$ 0	$ 12,377,907	$ 8,684	$ 3,833	$ (9,540,976)	$ 3,018,398

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss	$ (4,619,988)	$ (910,650)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	379,227	741
Beneficial conversion feature	0	79,156
Unearned stock compensation	0	170,137
Change in fair value of embedded conversion features	59,127	21,506
Issuance and amortization of warrants for services	0	80,402
Gain on settlement of contingent liabilities	(150,000)	0
Gain on licensing to related party	(240,000)	0
Loss on common stock issued for accounts payable	189,114	0
Amortization of debt discounts	187,902	0
Issuance of common stock for services	1,202,215	750,990
Loss on disposition of assets	295,400	0
Loss on conversion of debt	710,447	0
Vesting of stock-based compensation	114,658	0
Bad debt expense	637,817	0
Changes in operating assets and liabilities:
Accounts receivable	(99,310)	500
Inventory	(77,489)	2,465
Prepaid expense	(264,882)	(1,600)
Other receivable	0	(603,805)
Accounts payable and accrued expenses	654,146	(158,368)
Due to related parties	(79,276)	133,075
Net cash used in operating activities	(1,100,802)	(435,450)
Cash flows from (used in) investing activities
Investment in Irie	(356,000)	0
Cash received in acquisitions	19,442	0
Intangible asset acquired	0	(4,312)
Purchases of property and equipment	(47,878)	0
Net cash used in investing activities	(384,436)	(4,312)
Cash flows from financing activities:
Proceeds from the sale of common stock and warrants	1,388,558	150,000
Proceeds from capital contributed	0	21,082
Proceeds from related party	0	164,420
Repayments on notes payable	(149,765)	(25,000)
Proceeds from notes payable	166,842	130,000
Net cash provided by financing activities	1,405,635	440,502
Effects of exchange rates on cash	131,485	0
Net increase (decrease) in cash	51,882	740
Cash at beginning of period	2,498	1,758
Cash at end of period	54,380	2,498
Supplemental disclosure of cash flow information:
Cash paid for interest	0	13,400
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Issuance of common stock for accounts payable and accrued expenses	662,459	72,069
Issuance of common stock for inventory	27,200	0
Conversion of debt into common stock	0	239,026
Conversion of common stock into licensing agreement	0	(10,209)
Issuance of common stock for deposit on acquisition	0	(184,500)
Contingent liability for deposit on acquisition	0	(150,000)
Financed purchases of property and equipment	4,870,100	0
Common stock issued in business combination	1,298,243	0
Exercise of warrants for the issuance of common stock	215	0
Notes assigned between holders	118,602	0
Initial debt discounts	116,625	0
Common stock issued for settlement of debt	1,346,520	0
Common stock issued for rights agreement	22,000	0
Derivatives liability	0	286,504
Common stock issued for cost method investment	995,400	0
Common stock issued for patent acquisition	246,160	0
Common stock issued for prepaid royalties	$ 139,243	$ 0

1. Nature of Operations and Sum

1. Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Summary of Significant Accounting Policies	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization The Company was incorporated in the State of Nevada on February 21, 2013, under the name of Arkadia International, Inc. The Company was originally engaged in the business of the acquisition of in demand equipment, cars, and goods with the intent to resell these in the U.S. territories or export to overseas countries. On October 3, 2014, the Company experienced a change in control. Richard C. Cowan acquired approximately 93% of the issued and outstanding common stock of the Company at the time. On November 6, 2014, the Company merged with Freedom Leaf Inc., a private Nevada corporation, and the Company changed its name to Freedom Leaf Inc. In connection with the merger, the sole officer, director and stockholder of the private company, Clifford J. Perry, became an officer and director of the Company, and Mr. Perry received approximately 48.1% of the Company’s common stock post-merger. For financial reporting purposes, this merger was accounted for as a "reverse acquisition" rather than a business combination, and the private company was deemed to be the accounting acquirer in the transaction, with the Company deemed to be the acquired company for financial reporting purposes. Consequently, the assets and liabilities and the operations that were reflected in the historical financial statements of the Company prior to the merger are those of the private company, and they were recorded at the historical cost basis of the private company, and the financial statements after completion of the merger include the combined assets and liabilities of the Company and the private company, the historical operations of the private company only, and the operations of both companies from the closing date of the merger. Freedom Leaf Inc. is an audited and reporting public company traded under the symbol (OTCQB: FRLF) with corporate headquarters located at 3571 E. Sunset Road, Las Vegas, Nevada, 89120. Subsidiary Entities: · Cannabis Business Solutions Inc. (“Cannabis Business Solutions”), a Nevada corporation, was formed on February 5, 2014, and is a wholly-owned subsidiary of the Company. This subsidiary had no activity until the agreement with Valencia Web Technology S.L., B-97183354 (see Note 2). · Leafceuticals Inc. (“Leafceuticals”), formerly known as Cannabiz U, Inc., a Nevada corporation, was formed on February 13, 2014, and is a wholly-owned subsidiary of the Company. · Freedom Leaf International Inc. (“Freedom Leaf International”), a Nevada corporation, was formed on November 27, 2015, and is a wholly-owned subsidiary of the Company. This subsidiary has had no activity to date. · Leafceuticals Europe, SL, a wholly-owned subsidiary of the Company’s owns our Valencia greenhouse operations. · Freedom Leaf Cares Inc. (“Freedom Leaf Cares”), a Nevada corporation, was formed on October 1, 2014, and is a wholly-owned subsidiary of the Company. Freedom Leaf Cares was dissolved in 2016. Until dissolution, this subsidiary had no activity. Nature of Operations Freedom Leaf Inc. is a group of diversified, multinational, vertically-integrated hemp businesses and cannabis media companies. Freedom Leaf has strived to be a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industries since 2014, founded by professionals with Decades of combined experience in cannabis legalization advocacy. The Company is continuously building a diverse, global portfolio of valuable businesses and enterprises through strategic mergers, acquisitions, and acceleration projects across the hemp and cannabis industry. Utilizing these mergers and acquisitions, Freedom Leaf is building a solid foundation for our vertically-integrated hemp company to maximize both stockholder value and revenue growth. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp extract, which allows dramatically lower production costs for our wholly-owned hemp product lines, thereby generating more revenue for each product sold. We also formulate and manufacture the majority of our products in our own in-house formulation centers, also greatly reducing our costs and increasing revenue. In addition, our extensive domestic and international media companies ensure we can continuously direct traffic to our many ecommerce sites and nationwide retail locations. For valuation purposes, the Company’s focus is on developing and implementing multiple, mutually-reinforcing revenue streams; through which revenue, net income and stockholder value are maximized by cross-marketing across its brands and advertising through its media properties. The Company’s major business lines are: · Legal Industrial Hemp Cultivation · Cannabidiol Extraction, Distillation, and Processing · Expert Product Formulation · Nutraceutical Brand Marketing · Ancillary Products & Niche Markets · Affiliate Marketing Programs · E-Commerce Solutions · Global Media & Advertising Networks Basis of Presentation The Company prepares its consolidated financial statements in conformity with generally accepted accounting principles in the United States of America. Principles of Consolidation The consolidated financial statements include the accounts of Freedom Leaf and its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The Company consolidates any variable interest entities of which it is the primary beneficiary. Equity investments through which the Company exercises significant influence over but does not control the investee and is not the primary beneficiary of the investee’s activities are accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which do not have readily determinable fair values are accounted for under the cost method. All material inter-company accounts have been eliminated in the consolidation. Impairment of Long-Lived Assets The Company accounts for long-lived assets in accordance with the provisions of Statement of Financial Accounting Standards ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities. We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. We currently measure and report at fair value derivative liabilities. The fair value of derivative liabilities is measured using the Black-Scholes option pricing method. The following table summarizes our non-financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2018 and 2017: The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis at June 30, 2018: Balance at Quoted Prices Significant Significant (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ – $ – $ – $ – Total Financial Liabilities $ – $ – $ – $ – The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis at June 30, 2017: Balance at June 30, 2017 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ 52,757 $ – $ – $ 52,757 Total Financial Liabilities $ 52,757 $ – $ – $ 52,757 Following is a summary of activity through June 30, 2018 of the fair value of derivative liabilities valued using Level 3 inputs: Balance at June 30, 2017 $ 52,757 Note inception date fair value 6,370 Change in fair value during 2018 (59,127 ) Balance at June 30, 2018 $ – Stock-Based Compensation The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition provisions ASC Topic 505-50. The Company estimates the fair value of stock options at the grant date by using the Black-Scholes option-pricing model. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets. Reclassifications Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders’ equity as previously reported. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Accounts Receivable Accounts receivable consisted of amounts due from customers primarily for management fees. The Company considered accounts more than 30 days old to be past due. The Company used the allowance method for recognizing bad debts. When an account was deemed uncollectible, it was written off against the allowance. The Company generally does not require collateral for its accounts receivable. Management has recorded an allowance for doubtful accounts as of June 30, 2018 of $20,261 and $0 as of June 30, 2017. Inventory Inventory is recorded at the lower of cost or market and the cost of sales are recorded utilizing the first in first out (“FIFO”) method. The Company periodically evaluates the value of items in inventory and provides write-downs to inventory based on its estimate of market conditions. The Company estimated it needed an obsolescence allowance of $36,039 and $0 for the years ended June 30, 2018 and 2017, respectively, which was charged to cost of goods sold. Investments The Company uses the cost method to account for investments in businesses that are not publicly traded and for which the Company does not control or have the ability to exercise significant influence over operating and financial policies. In accordance with the cost method, these investments are recorded at lower of cost or fair value, as appropriate, and are classified as long-term. Under this method, the Company’s share of the earnings or losses of such investee companies is not included in the consolidated balance sheet or consolidated statements of operations and comprehensive income or loss. However, impairment charges are recognized in the consolidated statements of operations and comprehensive income or loss. If circumstances suggest that the value of the investee company has subsequently recovered, such recovery is not recorded. Investments held by the Company in businesses that are not publicly traded and for which the Company has the ability to exercise significant influence over operating and financial management are accounted for under the equity method. In accordance with the equity method, these investments are originally recorded at cost and are adjusted for the Company’s proportionate share of earnings, losses and distributions. The Company holds no such investments as of June 30, 2018 or 2017. The Company assesses and records impairment losses when events and circumstances indicate the investments might be impaired. Gains and losses are recognized when realized and recorded in other income (expense) in the accompanying Consolidated Statements of Operations and Comprehensive Loss. Property, Equipment and Depreciation Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of three years for computer equipment, five years for office furniture and fixtures, five years for machinery and equipment, thirty-nine years for buildings, and the lesser of the lease term or the useful life of the leased equipment. Leasehold improvements, if any, would be amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs along with fixed assets below our capitalization threshold are expensed as incurred. Variances between the two reporting periods are primarily due to foreign currency translation calculations. Goodwill Goodwill and Intangible Assets In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially valued at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of March 31, and whenever indicators of impairment exist. The fair values of intangible assets are compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value. Goodwill is reviewed for impairment annually, and more frequently as circumstances warrant, and written down only in the period in which the recorded value of such assets exceeds their fair value. The Company does not amortize goodwill in accordance with Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 350, "Intangibles—Goodwill and Other" ("ASC 350"). Goodwill is tested for impairment at the reporting unit level. The Company's two operating segments comprise the reporting unit for goodwill impairment testing purposes. The amortization of the intangible assets is computed using the straight-line method based on the estimated useful lives of the related assets of three years for website development, fifteen years for trademarks, one year for exclusive rights, nine years for trade names, two years for customer lists, one year for assembled workforce, and five years for patent. Variances between the two reporting periods are primarily due to foreign currency translation calculations. Accounting for Derivatives The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. Revenue Recognition The Company recognizes revenue for our services in accordance with ASC 605-10, "Revenue Recognition in Financial Statements." Under these guidelines, revenue is recognized on transactions when all of the following exist: persuasive evidence of an arrangement did exist, delivery of service has occurred, the sales price to the buyer is fixed or determinable and collectability is reasonably assured. The Company has five primary revenue streams as follows: · Advertising Services – Revenue from advertising is recognized over the contracted period in which advertising services are performed. Advertising services are considered performed when an ad is displayed to users. · Product Sales – Revenue from the sale of the Company’s branded products is recognized in the period in which product is shipped. Sales billed or cash received in advance of actual shipment are deferred and recorded as income in the period in which shipment is made. Shipping and handling fees billed to customers is included in net sales. Shipping and handling costs are expensed as incurred and included in cost of sales. All sales are presented net of sales taxes, which are excluded from revenue. · Licensing Revenue – Revenue from licensing arrangements is recognized when earned, estimable and realizable. The timing of revenue recognition is dependent on the terms of each license agreement and on the timing of sales of licensed products. The Company generally recognizes royalty revenue when it is reported to the Company by its licensees, which is generally one quarter in arrears from the licensees’ sales of licensed products. For licensing fees that are not determined by the licensees’ sales, the Company generally recognizes license fee revenue on a straight-line basis over the life of the license. Advertising and Marketing Advertising and marketing is expensed as incurred and is included in selling, general and administrative expenses on the accompanying statement of operations. For the years ended June 30, 2018 and 2017, advertising expense was $49,656 and $41,712, respectively. Income Taxes The Company adopted the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for unrecognized tax benefits. As of June 30, 2018, all previous tax years remain open for IRS audit. The Company has received no notice of audit from the IRS for any of the open tax years. The Company adopted ASC 740-10, “ Net Earnings (Loss) Per Share In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares that may dilute future earnings per share consist of warrants to purchase 4,518,167 shares of common stock at June 30, 2018. Equivalent shares are not utilized when the effect is anti-dilutive. Foreign Currency Translation and Transactions The Euro (“EUR,” or “€”) is the functional currency of Green Market Europe, S.L. and Leafceuticals Europe S.L.U., whereas the consolidated financial statements are reported in United States Dollar (“USD,” or “$”). Assets and liabilities are translated based on the exchange rates at the balance sheet date, while revenue and expense accounts are translated at the average exchange rates prevailing during the period. Equity accounts are translated at historical exchange rates. The resulting translation gain and loss adjustments are accumulated as a component of stockholders’ equity and other comprehensive income. Comprehensive Income (Loss) The Company reports comprehensive income (loss) and its components in its consolidated financial statements. Comprehensive income (loss) consists of net loss and foreign currency translation adjustments affecting stockholders’ equity that, under U.S. GAAP, are excluded from net loss. As of June 30, 2018, the exchange rate between U.S. Dollars and the Euro was USD $1.17 = €1.00, and the weighted average exchange rate for the period (acquisition date to end of fiscal year) ended June 30, 2018 was USD $1.20 = €1.00. Segment Information In accordance with the provisions of ASC 280-10, “Disclosures about Segments of an Enterprise and Related Information”, the Company is required to report financial and descriptive information about its reportable operating segments. The Company does not have any operating segments as of June 30, 2018 and 2017. Effect of Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (“ASC 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method, nor has it determined the effect of the standard on its ongoing financial reporting. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In February 2016, the Financial Accounting Standards Board (“FASB”) issued an ASU on lease accounting. The ASU requires the lease rights and obligations arising from lease contracts, including existing and new arrangements, to be recognized as assets and liabilities on the balance sheet. The ASU is effective for reporting periods beginning after December 15, 2018 with early adoption permitted. While the Company is still evaluating the ASU, the Company expects the adoption of the ASU to have a material effect on the Company’s financial condition due to the recognition of the lease rights and obligations as assets and liabilities. The Company does not expect the ASU to have a material effect on the Company’s results of operations, and the ASU will have no effect on cash flows. The Company has evaluated all other recent accounting pronouncements and believes that none of them will have a significant effect on the Company’s financial statement.

2. Entry Into a Definitive Agre

2. Entry Into a Definitive Agreement	12 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
Entry Into a Definitive Agreement	NOTE 2 – ENTRY INTO A DEFINITIVE AGREEMENT Freedom Leaf Inc. f/k/a Arkadia International, Inc., a Nevada corporation and the public company (the “Company,” “Public Company,” “we,” “us,” “our”) entered into a merger agreement with a private Nevada corporation, Freedom Leaf Inc. (the “Private Company”). Prior to the reverse merger, Richard C. Cowan, the officer and Director of the Public Company, had acquired the majority of its outstanding common stock. Clifford J. Perry, the Private Company’s sole officer and Director pre-merger (“Perry”), was the owner of record of all of the outstanding common shares of the Private Company (the “Private Company Stock”) prior to the merger. Pursuant to the merger, the Private Company was merged into the Public Company, and Perry, the Private Company’s stockholder, received 83,401.2 shares of Public Company common stock for each share of Private Company stock pre-merger, or 83,401,200 total shares of the Company’s common stock. The closing of the merger was conditioned upon certain, limited customary representations and warranties, as well as the satisfaction or waiver of specified conditions to closing. As the parties satisfied all of the closing conditions, we filed Articles of Merger in Nevada consummating the merger, and stockholders of the Private Company pre-merger (Perry) owned approximately 48.1% of our issued and outstanding common stock post-merger. Following the merger, the Company focused on pursuing Private Company’s historical businesses. The foregoing description of the merger agreement and transaction does not purport to be complete and is qualified in its entirety by the merger agreement, a copy of which has been filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q/A for the period ended December 31, 2014, which is incorporated herein by reference. Licensing Rights On February 8, 2016, the Company and Freedom Leaf Netherlands, B.V. (“FLNL”), a company located in the Netherlands, executed a Memorandum of Understanding (“MOU”), wherein the Company granted FLNL a right of first refusal to license certain rights from the Company described below in exchange for a payment of $25,000, and the parties agreed to negotiate a definite license agreement for such rights with the terms of the definitive agreement incorporating the material terms set forth in the MOU. Such rights include FLNL’s rights to use various trademarks of the Company, primarily “Freedom Leaf,” and other related rights, for use in the Netherlands by FLNL, including FLNL’s right to publish a Freedom Leaf magazine in the Netherlands, sell Freedom Leaf products and perform other activities related to the business of the Company. FLNL is a stockholder (common stock and warrants to purchase additional common stock) of the Company. On December 15, 2016, the Company and FLNL executed the license agreement. The agreement provided for a licensing fee of $250,000 with a payment schedule as follows: $70,869 which has been paid from the date of the MOU until the date of the agreement; $25,000 payment every two months, commencing on April 10, 2017 with the last payment on April 10, 2018, and a final payment of $4,131 on June 10, 2018. As of June 30, 2018, the Company has written the receivable of $179,131 off to bad debt. The Company also provided FLNL with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants were exercisable as follows: 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018; and 250,000 warrants between March 2018 and May 2018. See Notes 7 and 12. None of the warrants were exercised and, thus, have expired. The agreement was terminated on April 3, 2018. On December 15, 2016, the Company and Freedom Leaf Iberia, B.V. (“FLI”), a company incorporated under the laws of the Netherlands, executed a license agreement. The licensing agreement provides FLI the distribution rights to the Company’s magazine and other “Freedom Leaf” branded merchandise. The territory of the agreement is Spain and Portugal. The agreement provided for a license fee of $250,000 payable to the Company. The payment schedule provides for a $25,000 payment payable every two months, beginning on April 20, 2017, concluding on April 20, 2018, with a final payment of $75,000 on June 20, 2018. As the Company is allowing for progress payments, the balance is shown net of imputed interest on the balance sheet. The Company also provided FLI with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants can be exercised as follows: 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018; and 250,000 warrants between March 2018 and May 2018. The warrants have expired and are unexercised as of June 30, 2018. See Notes 8 and 12. As of June 30, 2018, the Company has written the receivable of $190,000 off to bad debt. On March 31, 2017, the Company entered into a license agreement with BBD Healthcare Strategies, LLC, a Florida limited liability company (“BBDHS”), pursuant to which BBDHS received distribution rights to the Company’s magazine and other “Freedom Leaf” branded merchandise for the State of Florida, in consideration of (1) a license fee of $250,000, paid $25,000 at execution, and $25,000 due August 2017, October 2017, December 2017, February 2018, March 2018, April 2018, May 2018 and concluding June 2018, with a final payment of $50,000, (2) ongoing royalties of 5% for sales of Company merchandise purchased from the Company, (3) ongoing royalties of 10% for sales of Company merchandise purchased from a third-party supplier, and (4) ongoing royalties of 33% for Company seminars and conferences. The Company also provided BBDHS with warrants to purchase 1,200,000 shares of Company common stock at an exercise price of $0.05, exercisable as follows: 240,000 shares between September 1, 2017 and October 31, 2017, 240,000 shares between November 1, 2017 and December 31, 2017, 240,000 shares between January 1, 2018 and February 28, 2018, 240,000 shares between March 1, 2018 and May 30, 2018, and 240,000 shares between June 1, 2018 and July 30, 2018. See Notes 8 and 12. As of June 30, 2018, the Company has written the receivable of $200,000 off to bad debt. As of June 30, 2018, all warrants are unexercised and expired. On May 15, 2018, the Company issued to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc. magazine, as well as other “Freedom Leaf” branded merchandise and services in the Southern California area. In consideration of such license, Cowan cancelled $240,000 of payables owed to him by the Company. Also, in connection with this transaction, the Company issued to Cowan a warrant, exercisable between July 1, 2018 and November 15, 2019, to acquire 1,000,000 shares at an exercise price of $0.01 per share. This has been reflected as other income (“Licensing income – related party”) in the consolidated statement of operations and comprehensive loss. Incubation Agreement On January 18, 2016, the Company and Plants to Paper, LLC (“PTP”), a New Jersey limited liability company, executed an Incubation Agreement. PTP owned the patent pending application 62/245,153 (the “Patent”) with the title being “Rolling Papers and Blunt Wraps made from 100% Marijuana.” PTP agreed to transfer its ownership rights in the patent application to the Company, as well as PTP’s Medical Marijuana / Cannabis/Hemp Industry Incubator program. The Company agreed to supply management services and to fund the early stage development of PTP. The Incubation Agreement was for a period of twelve months. PTP will provide the Company with 20% of the outstanding membership shares of PTP in exchange for its services. The costs of patent registrations in the United States and other countries will be the liability of PTP. On February 1, 2017, the Agreement was modified for the following items: a) to provide 25% of the outstanding membership shares of PTP; b) require that the Patent be assigned to PTP; and c) acknowledge that the ownership rights have not been transferred to the Company as of that date. To-date, ownership rights have not been transferred. This agreement expired on January 18, 2017. Sales Representation Contract On December 22, 2016, the Company and NuAxon BioScience, Inc. (“NuAxon”), a Delaware corporation, executed a Sales Representation Contract. NuAxon is a manufacturer and distributor for bulk extracts, Rebel Herbs brand products, and Intelligence Tree brand products. The contract appoints the Company as NuAxon’s sales representative worldwide. The contract is for a period of one year and shall automatically renew for successive terms of the same duration. The contract provides a commission for sales by the Company at rates as follows: a) bulk extracts is 9% with a 2% bonus on annual sales above $500,000; b) Rebel Herbs and Intelligence Tree brand products is 10% with a 3% bonus on annual sales above $1,000,000. As of June 30, 2018, there have been no sales or commissions earned. Equipment Sales Representative Contract On December 22, 2016, the Company and NuAxon executed an Equipment Sales Representative Contract. NuAxon is a manufacturer and distributor for extraction equipment. The contract appoints the Company as NuAxon’s equipment sales representative worldwide. The contract is for a period of one year and shall automatically renew for successive terms of the same duration. The contract provides a commission for sales by the Company at various rates ranging from 3% to 10%, dependent on the cumulative annual sales. On March 15, 2017, the Company entered into an Exclusive Distribution Agreement with NuAxon to sell NuAxon’s CO2 extraction equipment pursuant to which the Company would be paid increasing commissions depending on gross sales of the equipment. On March 16, 2017, the Company issued a purchase order (the “Purchase Order”) to NuAxon to purchase extraction equipment for one of the Company’s customers. As of June 30, 2018, there have been no sales.

3. Business Combination

3. Business Combination	12 Months Ended
	Jun. 30, 2018
Business Combinations [Abstract]
Business Combination	NOTE 3 –BUSINESS COMBINATION AND ASSET ACQUISITIONS IRIE Acquisition On April 16, 2018, Leafceuticals consummated the acquisition, with an effective date of April 1, 2018 (date of change in control), of substantially all of the assets of: Earth Born, Inc., a California corporation (“Earth Born California”), Earth Born, Inc., a Delaware corporation (“Earth Born Delaware”), Irie Living, a California nonprofit mutual benefit corporation (“Irie”), and Genesis Media Works, LLC, a Utah limited liability company doing business as “Terra’s Way,” “Irie Hemp Company,” “Earth Born Botanicals,” and “Santa Cruz Hemp Company” (“Genesis” and together with Earth Born California, Earth Born Delaware, and Irie, collectively referred to herein as the “Sellers” or IRIE). Irie CBD is a California-based product line owned by the Sellers that has been operating since 2015 that formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets across the country. IRIE leases a full manufacturing and processing facility in Oakland, California. In addition to the IRIE CBD line and associated assets and trademarks, the acquisition also includes the product lines, websites and other assets of Earth Born California, Earth Born Delaware, Irie, and Genesis. In connection with this acquisition, Leafceuticals assumed approximately $100,000 of liabilities associated with the assets and paid the Sellers’ principals as follows: $356,080 in cash and $999,000 via the issuance of an aggregate of 8,118,886 shares of the Company’s common stock. The purchase price is to be reduced if: (i) the Sellers’ aggregate pre-closing revenues for the year ending December 31, 2017, were less than $1,500,000 or (ii) the Buyer’s average monthly revenues resulting from the Acquisition of the Assets for the three months following closing are less than $120,000 per month. Additionally, 1,250,000 of the Shares were to be escrowed for four months following Closing as the Buyer’s security for (i) any indemnification claims against the Sellers pursuant to the Agreement, or (ii) any pre-closing or post-closing revenue deficiency resulting in the purchase price reductions described above. There was no adjustment to the purchase price based on this clause. Assets acquired, and liabilities assumed, at fair value: The fair value of the purchase consideration issued to the sellers of IRIE was allocated to the net tangible assets acquired. We accounted for the acquisition of IRIE as the purchase of a business under GAAP under the acquisition method of accounting, the assets and liabilities acquired were recorded as of the acquisition date, at their respective fair values and consolidated with those of our company. The fair value of the net assets acquired, net of liabilities assumed, was approximately $1,455,000. The excess of the aggregate fair value of the net tangible and intangible assets has been treated as goodwill. Consideration given: Cash Consideration $ 356,000 Common stock shares given 999,000 Notes Assumed 100,000 Total consideration given $ 1,455,000 Fair value of identifiable assets acquired, and liabilities assumed: Current Assets $ 226,000 Current Liabilities 44,000 Net Working Capital 182,000 Property, Plant & Equipment 25,000 Trade Names/Trademarks 327,000 Customer Contracts/Relationships 712,000 Assembled Workforce 139,000 Goodwill 70,000 Total Consideration $ 1,455,000 The following presents the pro-forma combined results of operations of the Company with IRIE as if the entities were combined on July 1, 2017. For the Year Ended June 30, 2018 Revenues, net $ 1,629,730 Net loss allocable to common stockholders (305,757 ) Net loss per common share $ (0.00 ) Weighted-average number of share outstanding 149,199,226 Revenue recognized by IRIE from acquisition through June 30, 2018 was $393,480. The pro-forma results of operations are presented for information purposes only. The pro-forma results of operations are not intended to present actual results that would have been attained had the acquisitions been completed as of January 1, 2016 or to project potential operating results as of any future date or for any future periods. Greenhouse Purchase The Company, on May 17, 2018, consummated the acquisition of an existing, approximately 430,000 square foot facility, that has converted from a dormant Poinsettia production facility into a light deprivation hemp production greenhouse. The total purchase price was €4,000,000 (approximately US$4.8million). The purchase consideration will be paid as follows: (i) €20,000 down, which amount already has been paid by the Company; (ii) €20,000 a month for 25 months, and (iii) €100,000 per month thereafter until paid in full. Located in Valencia, the third largest city in Spain with an average of 300 days of sun per year and agricultural setting, the facility previously was one of the biggest Poinsettia producers in Europe. At its peak, it produced millions of Poinsettia clones and had more than 80 greenhouse workers working 24/7. The Company chose this facility due to the similarities in growing Poinsettias and Hemp and because of its light cycles and heavy machinery specific to industrial plant production. This turn-key facility includes: approximately 430,000 square feet of light deprivation greenhouse, growing supplies, polished concrete, and triple galvanized steel framework. It its fully equipped with an automated irrigation system, a mist system, a refrigerated storage area, a light deprivation system to maximize number of crops per year, a Dutch, hydroponic set up and heating system, its own gas pipe, and five sources of irrigation water with reservoir. The facility also has office space that the Company intends to utilize to house: (i) our Spanish Media department (lamarihuana.com) and (ii) a warehouse. The purchase also includes outdoor space and the necessary structural steel sufficient to erect a new 64,000 sq. ft galvanized steel frame facility the Company intends to build to use as a GMP extraction, formulation and bottling facility. The Company intends to retain the predecessor operation’s key employees to maintain the growing facilities. Management’s goal is for this facility to become a leading greenhouse producer of cannabinoids in Europe. The Company’s goal is to grow up to two million grams of EU-certified Industrial Hemp in its first year of operations and then to expand significantly in subsequent years. The Company also expects to utilize this facility to increase its Hemp research, tissue culture and extraction capabilities in the following years. Green Market Europe Purchase On January 5, 2018 as amended on February 5, 2018, with an effective date of January 5, 2018, the Company consummated its previously-announced acquisition of 100% of the capital stock of Green Market Europe, S.L. (“GME”), a Spanish producer of hemp products. GME’s facilities include: a 21,000 square foot light deprivation greenhouse; a 43,000 square foot indoor growing research facility, and over 200 acres of outdoor production space. The light deprivation allows the increase of the number of yearly crops from 3 to 4 crops a year, and the 43,000 square foot indoor grow facility is used for genetic research and cultivating additional hemp crops. GME is strategically located in Elche, Alicante, an important Spanish business hub, with great year-round weather conditions for agricultural growing and a long tradition of growing hemp. From its inception to-date, GME has had negligible operations. Purchase Consideration: In consideration for the acquisition, the Company paid to GME’s seller $320,205 in cash and Company common stock as follows: (i) $24,805 (which amount was paid by a third party, and to whom the Company owes that amount), and (ii) 4,220,000 shares of the Company’s common stock valued on the Company’s Balance Sheet at $295,400. Additionally: (i) additional shares will be issuable if the volume weighted-average price of the Company’s stock between January 5, 2018 and July 3, 2018 is less than $0.10 per share, and (ii) the sellers of GME have the option to repurchase all of the assets of GME for €100 (and the assumption of GME’s liabilities) if the volume weighted-average price of the Company’s stock between January 5, 2018 and January 5, 2019 is less than $0.01 per share. Assets acquired, and liabilities assumed, at fair value: The provisional fair value of the purchase consideration issued to the sellers of GME was allocated to the net tangible assets acquired. We accounted for the acquisition of GME as the purchase of a business under GAAP under the acquisition method of accounting, the assets and liabilities acquired were recorded as of the acquisition date, at their respective fair values and consolidated with those of our company. The fair value of the net assets acquired, net of Liabilities assumed, was approximately $20,285. The excess of the aggregate fair value of the net tangible assets has been treated as Goodwill. The purchase price allocation was based, in part, on management’s knowledge of GME’s business and is preliminary. Once we complete our analysis to finalize the purchase price allocation, which includes finalizing the valuation report from a third-party appraiser and a review of potential intangible assets, it is reasonably possible that, there could be significant changes to the preliminary values below. Consideration given: Common stock shares given $ 295,400 Total consideration given $ 295,400 Fair value of identifiable assets acquired, and liabilities assumed: Cash $ 3,546 Accounts receivable 7,430 Fixed assets, net 64,891 Intangible assets, net 5,176 Accounts payable (71,478 ) Acquisition payable (24,805 ) Payable to stockholders (5,045 ) Total identifiable net liabilities (20,285 ) Goodwill 315,685 Total consideration $ 295,400 During March, April and May of 2018, in connection with the Company’s preliminary audit of GME, the Company’s management discovered several irregularities regarding GME’s operations and its sellers’ activities before and after the consummation of the Company’s acquisition of that business. Based on investigation of these discoveries, the Company, effective June 4, 2018, consummated a termination agreement with GME’s seller. In connection with that agreement, GME’s sellers returned to the Company the 4,220,000 shares it had previously issued to the sellers. The Company wrote off the approximately $33,000 it had invested cumulatively in GME in addition to the stock issuance and recognized a non-cash loss of $295,400 upon disposition of this business. Valencia Purchase The Company, on May 17, 2018, consummated the acquisition of existing, approximately 430,000 square foot facility, that was converted from a dormant Poinsettia production facility into a light deprivation hemp production greenhouse. The total purchase price was €4,000,000 (approximately US$4.8million). The purchase consideration will be paid as follows: (i) €20,000 down, which amount already has been paid by the Company; (ii) €20,000 a month for 25 months, and (iii) €100,000 per month thereafter until paid in full. Located in Valencia, the third largest city in Spain with an average of 300 days of sun per year and agricultural setting, the facility previously was one of the biggest Poinsettia producers in Europe. At its peak, it produced millions of Poinsettia clones and had more than 80 greenhouse workers working 24/7. The Company chose this facility due to the similarities in growing Poinsettias and Hemp and because of its light cycles and heavy machinery specific to industrial plant production. This turn-key facility includes: approximately 430,000 square feet of light deprivation greenhouse, growing supplies, polished concrete, and triple galvanized steel framework. It its fully equipped with an automated irrigation system, a mist system, a refrigerated storage area, a light deprivation system to maximize number of crops per year, a Dutch, hydroponic set up and heating system, its own gas pipe, and five sources of irrigation water with reservoir. The facility also has office space that the Company intends to utilize to house: (i) our Spanish Media department (lamarihuana.com) and (ii) a warehouse. The purchase also includes outdoor space and the necessary structural steel sufficient to erect a new 64,000 sq. ft galvanized steel frame facility the Company intends to build to use as a GMP extraction, formulation and bottling facility. The Company intends to retain the predecessor operation’s key employees to maintain the growing facilities. Management’s goal is for this facility to become a leading greenhouse producer of cannabinoids in Europe. The Company’s goal is to grow up to two million grams of EU-certified Industrial Hemp in its first year of operations and then to expand significantly in subsequent years. The Company also expects to utilize this facility to increase its Hemp research, tissue culture and extraction capabilities in the following years. For accounting purposes, the Company is treating the transaction as an asset purchase vs. a business combination. The transaction does not meet the standard necessary, per ASC 805-10, for the transaction to be characterized as a business combination as, among other reasons: the prior business, a poinsettia farm, had been out of business for a number years; the Company, post-acquisition, converted the assets acquired into a totally different business, and the Company employed none of the employees of the former business. LaMarihuana Purchase On May 30, 2017, with an effective date of April 8, 2017 as per the Bill of Sale, Cannabis Business Solutions Inc. (the “Buyer”), a wholly-owned Nevada subsidiary of the registrant, Freedom Leaf Inc., entered into an Asset Purchase Agreement with Valencia Web Technology S.L., B-97183354, a Spanish limited liability company (Sociedad de Responsabilidad Limitada) (the “Seller,” or “Valencia”) to purchase the Seller’s assets, including its cash and cash equivalents, equipment, inventory, receivables, and two of its websites www.lamarihuana.com and www.marihuana-medicinal.com (but not including the Seller’s website cannabislandia.com), for a purchase price consisting of a 10% interest in the Buyer, and 3,000,000 shares of common stock of the registrant, valued at $300,000 (the “Initial FRLF Shares”), with additional shares of the registrant’s common stock due six months (October 8, 2017) following closing if, at such time, the average closing price of the registrant’s common stock during the previous five trading days is less than $0.10/share. Such additional shares shall be calculated as follows: $300,000 minus the product of (a) the Initial FRLF Shares multiplied by (b) the average closing price of the registrant’s common stock during the five trading days immediately preceding the True-Up Date (the “True-Up Price”), with such difference divided by the True-Up Price. On October 8, 2017, the Company removed the previously recorded contingent liability and recorded 4,142,857 shares of common stock as issuable. On February 7, 2018, the Company and the Buyer agreed that because of the increase in the value of the Company’s common stock, the Buyer had waived its right to additional shares of common stock as stated herein. Therefore, on February 7, 2018, the Company reversed its recording of the 4,142,857 shares of common stock recorded as issuable. The Company is in the process of meeting international requirements for the complete use of the web sites by the Company. This process is expected to be completed before the end of fiscal year 2019.

4. Going Concern

4. Going Concern	12 Months Ended
	Jun. 30, 2018
Going Concern
Going Concern	NOTE 4 – GOING CONCERN The Company has a net loss attributable to common stockholders for the year ended June 30, 2018 of $4,628,673 and working capital as of June 30, 2018 of $1,081,685 and has used cash in operations of $1,100,802 for the year ended June 30, 2018. In addition, as of June 30, 2018, the Company had a stockholders’ equity and accumulated deficit of $3,018,398 and $9,540,976, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The ability of the Company to continue its operations is dependent on the execution of management’s plans, which include the raising of capital through the debt and/or equity markets, until such time that funds provided by operations are sufficient to fund working capital requirements. If the Company were not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in the preparation of the consolidated financial statements. There can be no assurances that the Company will be successful in generating additional cash from the equity/debt markets or other sources to be used for operations. The consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary. Based on the Company’s current resources, the Company will not be able to continue to operate without additional immediate funding. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.

5. Commitments and Contingencie

5. Commitments and Contingencies	12 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of October 15, 2018, there were no pending or threatened lawsuits. Lease Commitment We lease approximately 2,800 square feet of office space in Las Vegas, Nevada, pursuant to a lease that will expire on April 15, 2019. This facility serves as our corporate headquarters. After December 31, 2018, the Company has the option to opt out of the lease. Future minimum lease payments under these leases are as follows: 2019 $ 29,646 Total $ 29,646 Rent expense for the years ended June 30, 2018 and 2017 was $32,046 and $39,600, respectively. We also lease approximately 1,777 square feet of office and production space, used by Irie in Oakland, California, pursuant to a lease that will expire June 30, 2019. Future minimum lease payments under these leases are as follows: 2019 $ 40,700 Total $ 40,700 Rent expense for the years ended June 30, 2018 was $16,564.

6. Related Parties

6. Related Parties	12 Months Ended
	Jun. 30, 2018
Related Party Transactions [Abstract]
Related Parties	NOTE 6 – RELATED PARTIES Richard Cowan (“Cowan”), a former Director and officer of the Company, has payables and accruals due to him of $15,485 and $269,225 as of June 30, 2018 and 2017, respectively, as reflected on the balance sheet under Accounts Payable and Accrued Expenses. The payable, as agreed upon verbally, has a maturity date greater than one year, without any other set terms for repayment. Imputed interest is immaterial. On May 15, 2018, the Company issued to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc. magazine, as well as other “Freedom Leaf” branded merchandise and services in southern California. In consideration of such license, Cowan cancelled $240,000 of payables owed to him by the Company. Also, in connection with this transaction, the Company issued to Cowan a warrant, exercisable between July 1, 2018 and November 15, 2019, to acquire 1,000,000 shares at an exercise price of $0.01 per share. Clifford J. Perry (“Perry”), Chief Executive officer, Chief Financial Officer, and a Director of the Company, has compensation due and other payables and accruals due to him totaling $32,813 and $133,944 as of June 30, 2018 and 2017, respectively, as reflected on the balance sheet under Accounts Payable and Accrued Expenses. Imputed interest is immaterial. On July 31, 2017, the Company issued 5,784,061 shares of common stock to Cliff Perry for accrued compensation of $112,500 owed to him as of June 30, 2017 and recorded a loss on settlement of liabilities of $130,431. Raymond P. Medeiros (“Medeiros”), a Director of the Company, has compensation due and other payables and accruals due to him totaling $63,000 and $52,500 as of June 30, 2018 and June 30, 2017, respectively, as reflected on the balance sheet under Accounts Payable and Accrued Expenses. Imputed interest is immaterial. On July 31, 2017, the Company issued 2,699,228 shares of common stock to Raymond Medeiros for accrued compensation of $52,500 owed to him as of June 30, 2017 and recorded a loss on settlement of liabilities of $60,368. On October 31, 2017, the Company issued 850,000 shares of common stock to Paul F. Pelosi, Jr. (“Pelosi”), in regard to his appointment as Chairman of the Board on November 1, 2017, for compensation for the period November 1, 2017 through January 31, 2018. The Company was obligated to issue on February 1, 2018, an additional 1,250,000 options for common stock with an exercise price of $0.04, with an expiration date eighteen months after the issuance. On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in satisfaction of this obligation. The warrants have an exercise price of $0.04 and expire August 11, 2018 (see Note 8). On November 10, 2017, the Company sold 967,000 shares of common stock to Pelosi for $14,500, based on a per share price of $0.01499. On January 18, 2018, Pelosi purchased 1,050,000 shares of common stock for $21,000. On July 27, 2018, the Company agreed to sell to Paul T. Pelosi Jr Two Million Two Hundred Thousand (2,200,000) shares of the Company’s 144 common stock for the price of Thirty Eight Thousand dollars ($38,500), $0.0175 per share, in consideration for which Pelosi agreed to: (1) cancellation and return of the previously issued to him and exercisable into 1,250,000 shares of Company common stock at $0.04 per share and (2) the cancellation of the Company’s obligation to issue to him 850,000 shares of Company common stock. On January 18, 2018, the Company appointed Richard Groberg, via his company, RSGroberg Consulting, LLC, as its Chief Financial Officer to serve for an initial, two-year term. In consideration of the services to be performed by Groberg, the Company: (i) issued 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its Directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. The 800,000 and 600,000 shares of common stock were issued on January 18, 2018 and valued at $81,200 and $60,900, respectively. On May 10, 2018, the Company appointed its CFO, Richard Groberg, as a member of the Company’s Board of Directors. In consideration of his appointment, the Company agreed to issue to Mr. Groberg’s entity (1) $50,000 in common stock to vest monthly over a one-year period, at a value of $0.16 per share, for a total of 312,500 shares, and (2) an eighteen-month warrant to acquire 500,000 shares of common stock of the Company at an exercise price of $0.10 per share. On April 30, 2018, the Company appointed Nevada State Senator Richard Segerblom as a member of the Company’s Board of Directors and issued to Senator Segerblom (i) $50,000 in common stock to vest monthly for one year, with a value of $0.159 per share, for a total of 314,465 shares of common stock, and (ii) an eighteen-month warrant to acquire 500,000 shares of common stock at an exercise price of $0.10 per share. On May 15, 2018, the Company issued to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc. magazine, as well as other “Freedom Leaf” branded merchandise and services in Southern California. In consideration of such license, Cowan cancelled $240,000 of payables owed to him by the Company. Also, in connection with this transaction, the Company issued to Cowan a warrant, exercisable between July 1, 2018 and November 15, 2019, to acquire 1,000,000 shares at an exercise price of $0.01 per share.

7. Convertible Notes Payable, N

7. Convertible Notes Payable, Net of Premiums and Notes Payable	12 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Convertible Notes Payable, Net of Premiums and Notes Payable	NOTE 7 – CONVERTIBLE NOTES PAYABLE, NET OF PREMIUMS AND NOTES PAYABLE Convertible notes payable, all classified as current at June 30, 2018, consist of the following: Convertible notes, net of discounts and notes payable June 30, 2018 June 30, 2017 Principal Principal, Debt net of Debt net of Principal Discounts Discounts Principal Discounts Discounts Baytown Holdings (b) $ 95,000 $ – 95,000 $ – $ – $ – Valencia (c) 4,629,486 – 4,629,486 – – – Irie (c) 99,000 – 99,000 – – – Pure Energy (a)(b) – – – 15,475 (7,489 ) 7,986 Pure Energy (a)(b) – – – 13,480 (5,565 ) 7,915 Power Up (a)(b) – – – 75,000 (39,330 ) 35,670 Power Up (a)(b) – – – 38,000 (18,893 ) 19,107 Total $ 4,832,486 $ – $ 4,832,486 $ 141,955 $ (71,277 ) $ 70,678 Short-term notes payable (95,000 ) – (95,000 ) - - - Current portion of long-term notes payable (286,575 ) – (286,575 ) - - - Long-term portion $ 4,441,911 $ – $ 4,441,911 $ 141,955 $ (71,277 ) $ 70,678 (a) Convertible (b) Short-term (c) Long-term Convertible Notes On July 7, 2015, the Company executed a convertible promissory note for $5,000 with Bruce Perlowin. The note is for one year, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.085, which is less than the conversion price. The stock price for our common stock as of September 30, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $5,000 was recorded and subsequently amortized. The Company has recorded accrued interest of $467 as of June 30, 2018. On April 15, 2016, Mr. Perlowin converted the principal of this promissory note into 50,000 shares of common stock. The accrued interest was not converted. On August 12, 2015, the Company executed a convertible promissory note for $5,000 with Bruce Perlowin. The note is for one year, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.10, which is less than the conversion price. The stock price for our common stock as of September 30, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $5,000 was recorded and subsequently amortized. The Company has recorded accrued interest of $408 as of June 30, 2018. On April 15, 2016, Mr. Perlowin converted the principal of this promissory note into 50,000 shares of common stock. The accrued interest was not converted. On August 20, 2015, the Company executed a convertible promissory note for $12,500 with Svetlana Ogorodnikova. The note matures on February 19, 2016, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.085, which is less than the conversion price. The stock price for our common stock as of December 31, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $12,500 was recorded and subsequently amortized. The Company has recorded accrued interest of $986 as of June 30, 2018. On February 19, 2016, Ms. Ogorodnikova granted the Company an extension on the due date to June 30, 2016. On April 15, 2016, Ms. Ogorodnikova converted the principal of this promissory note into 125,000 shares of common stock. The accrued interest was not converted. On November 1, 2016, the Company executed a collateralized secured promissory note with Eagle Equities, LLC (“Eagle”) for $25,000. The Company netted $23,000 due to legal fees of $2,000. The note has a conversion discount of 45% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $25,000 and as of December 31, 2017, had recorded $25,000 of amortization. The note matures on November 1, 2017 and bears interest at 8%. On April 26, 2017, Eagle sold its convertible note to PureEnergy 714 LLC (“PureEnergy”) with no change in terms. As of June 30, 2018, there is $0 of accrued interest. On June 29, 2017, the Company issued 791,140 shares of common stock to PureEnergy for the conversion of $12,501. On July 19, 2017, the Company issued 748,934 shares of common stock to PureEnergy related to the conversion of $13,481. On May 23, 2017, the Company executed a convertible promissory note with PureEnergy for $15,475. The note has a conversion discount of 45% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $8,481. The note matures on February 23, 2018 and bears interest at 8%. On October 30, 2017, the balance of the note and the accrued interest was converted into 1,006,768 shares of common stock. See Note 8. On May 10, 2017, the Company executed a convertible promissory note with Power Up for $75,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The note matures on February 23, 2018 and bears interest at 8%. On September 28, 2017, Pure Energy purchased the May 10, 2017 convertible promissory note between the Company and Power Up. The Power Up convertible promissory note was for $78,427. The Company and Pure Energy entered into a revised convertible promissory note to replace the Power Up convertible promissory note as stated below. On November 9, 2017, Pure Energy converted the entire note and accrued interest into 5,764,490 shares of common stock. See Note 8. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 that the Company issued to Pure Energy on September 27, 2017 in conjunction with Pure Energy’s payoff of the May 10, 2017 Power Up convertible note. On June 20, 2017, the Company executed a convertible promissory note with Power Up for $38,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $19,611 and as of the date of pay off, had recorded $6,609 of amortization. The note matures on February 23, 2018 and bears interest at 8%. On December 15, 2017, the principal and accrued interest was paid in full. On July 20, 2017, the Company executed a convertible promissory note with Power Up for $38,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $14,829 and as of March 31, 2018, had recorded $7,455 of amortization. The note matures on August 11, 2018 and bears interest at 8%. As of March 31, 2018, there is $0 of accrued interest. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it previously acquired from Power Up and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total). That note, executed by the Company on July 20, 2017, had a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. In conjunction with its conversion of that note, on January 19, 2018, Pure Energy also received 800,918 shares of common stock – (i) $19,826.19 in conjunction with the settlement amount owed by the Company to Power Up at the time Pure Energy acquired that note from Power Up in connection with that note, and (ii) $3,000 as a transaction fee ($22,826.19 in total). On August 11, 2017, the Company executed a convertible promissory note with LG Capital (“LG”) for $42,000. The note has a conversion discount of 35% based on the lowest closing price of the 12 days prior to conversion. On February 1, 2018, the Company paid LG Capital $58,813 to retire the convertible promissory note it issued to LG Capital on August 11, 2017 for $42,000. The repayment amount included $1,565 of accrued interest and a payment premium of $15,248. On September 26, 2017, the Company executed a convertible promissory note with Power Up for $53,000. The note has a conversion discount of 35% based on the lowest closing price of the 10 days prior to conversion. On February 8, 2018, the Company paid Power Up $71,913 to retire in full this convertible note. On September 27, 2017, the Company executed a convertible promissory note with Pure Energy for $78,427 to replace the May 10, 2017 convertible note with Power Up, as reflected above. The note has a conversion discount of 35% based on the lowest closing price of the 12 days prior to conversion. On November 9, 2018, the principal and accrued interest was converted into 5,765,490 shares of common stock. (See Note 12.) In conjunction with the payoff of the May 10, 2017 Power Up convertible note, the Company incurred a prepayment penalty of $28,496, which Pure Energy paid to Power Up. The Company issued a second convertible promissory note to Pure Energy, in consideration of its payment to Power Up, for $33,842, which included the prepayment penalty and legal fees of $5,346. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 (see Note 12). On January 17, 2018, Pure Energy acquired from Power Up the $38,000 note executed by the Company on July 20, 2017. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it acquired from Power Up on January 17, 2018 and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total) (see Note 12). Non-convertible Notes On June 4, 2018, the Company borrowed $95,000 from Baytown Holdings, LLC, $10,000 of which was withheld as an original issue discount (“OID”) and the $85,000 of net proceeds of which was advanced to P2P to fund working capital in connection with orders received by P2P (a cost method investee of the Company). The loan bears no interest, other than the OID and is due in full on September 5, 2018. Subsequent to year end, P2P has repaid the Company $95,000; and, the Company has repaid $95,000 to Baytown. Effective with the Company’s purchase of the Valencia, Spain greenhouse on June 30, 2018, for which the Company committed to pay €4,000,000 (approximately US$4.7 million and paid €20,000 down, it committed to pay: (ii) €20,000 a month for 25 months, and (iii) €100,000 per month thereafter until paid in full. There is 0% interest on the first 25 monthly payments and the interest rate on the remaining balance is 5%. The note is due on June 30, 2023. The principal balance as of June 30, 2018, was $4,348,911. In connection with the IRIE acquisition, the Company assumed a $100,000 Note, which bears no interest and is payable at the rate of $500 per month with the balance due on March 3, 2020. The principal balance was $93,000.

8. Stockholders' Equity

8. Stockholders' Equity	12 Months Ended
	Jun. 30, 2018
Equity [Abstract]
Stockholders' Equity	NOTE 8 – STOCKHOLDERS’ EQUITY Series A Preferred Stock On May 24, 2016, the Board of Directors of the Company authorized amending the Company’s Articles of Incorporation to authorize 10,000,000 shares of “blank check” preferred stock and designate 1,000,000 of the shares as Series A preferred stock. Each share of the Series A preferred stock is entitled to 500 votes and is convertible into 100 shares of common stock. On May 25, 2016, Perry converted 68,401,200 shares of common stock into 684,012 shares of Series A preferred stock. On May 25, 2016, Cowan converted 26,401,000 shares of common stock into 264,010 shares of Series A preferred stock. Common Stock The Company is authorized to issue up to 75,000,000 shares of common stock, par value $0.001 per share. On January 21, 2015, the Company increased its authorized capital to 500,000,000 shares of common stock. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights. The Company made the following issuances during the year ended June 30, 2018 of shares recorded as issuable as of June 30, 2017, as disclosed in the June 30, 2017 subsequent events: 177,032 shares of common stock to Rene Velez 200,000 shares of common stock to Jason Edwards 596,163 shares of common stock to Michael Ostrander 400,000 shares of common stock to Jason Edwards 120,000 shares of common stock to a consultant of the Company 300,000 shares of common stock to Michael Ostrander On June 30, 2017, 109,308,600 shares were outstanding. The following shares were issued from July 1, 2017 through June 30, 2018: On July 19, 2017, the Company issued 748,934 shares of common stock to PureEnergy related to the conversion of $13,481 of a convertible promissory note. On July 31, 2017, the Company issued 5,784,061 shares of common stock to Cliff Perry for accrued compensation of $112,500. See Note 6. On July 31, 2017, the Company issued 2,699,228 shares of common stock to Raymond Medeiros for accrued compensation of $52,500. See Note 6. On August 14, 2017, the Company issued 500,000 shares of common stock to Nuaxon Bioscience as part of the agreement for exclusive rights to market and sell their equipment. The shares were valued at $22,000. On August 17, 2017, the Company issued 345,451 shares of common stock to Lakeport Business Services, Inc. for accounts payable $9,450. The shares were valued at $24,182. On August 23, 2017, the Company issued 500,000 shares of common stock to Frank Dobrucki for future services. On August 25, 2017, the Company issued 600,000 shares of common stock to Christopher Thompson as a bonus in August 2017. The shares were valued at $48,900. On August 25, 2017, the Company issued 550,000 shares of common stock to Joshua Halford for services in August 2017. The shares were valued at $44,825. On August 28, 2017, the Company issued 1,061,500 shares of common stock to Christopher Sloan for services in August 2017 (661,500 shares) and for accrued expenses of $23,075 (400,000 shares of common stock). The shares were valued at $137,535. On August 28, 2017, the Company issued 530,303 shares of common stock to Neil Dutson for services valued at $37,203. On August 29, 2017, the Company issued 100,000 shares of common stock to Marc Hatch for services valued at $7,430. On August 29, 2017, the Company issued 100,000 shares of common stock to Marc Hatch for services valued at $7,430. On October 6, 2017, the Company issued 400,000 shares of common stock to Jason Edwards for services in October 2017 valued at $16,280. On October 6, 2017, the Company issued 600,000 shares of common stock to Michael Ostrander for services in October 2017 valued at $24,420. On October 7, 2017, due to the agreement with Valencia (see Note 2), the Company owed Valencia an additional 4,142,857 shares of common stock, which were recorded as issuable. The Company recorded a contingent liability of $174,000 associated with this obligation. On January 29, 2018, because of the increase of the Company’s common stock, Valencia agreed to the accept the initially issued 3,000,000 shares of common stock as satisfaction of the obligation to pay to Valencia in connection with the Company’s May 30, 2017 Asset Purchase Agreement with Valencia to acquire certain of its assets without the need to issue additional true-up shares of the Company’s common stock. The January 29, 2018 agreement relieved the Company of the contingent liability of issuing additional shares. See Note 17. On October 23, 2017, the Company issued 1,001,250 shares of common stock to Timothy Puetz for services in October 2017 valued at $30,038. On October 23, 2017, the Company issued 1,000,000 shares of common stock to Breadfruit Tree, Inc. for inventory received in October 2017 valued at $27,200. On October 26, 2017, the Company issued 255,000 shares of common stock to Ronald Voight for services in October 2017 valued at $7,650. On October 28, 2017, the Company issued 273,333 shares of common stock to Lakeport Business Services, Inc. for services in October 2017 valued at $8,200. On October 28, 2017, the Company issued 30,000 shares to Neil Dutson for leasehold improvement performed in October 2017 valued at $900. On October 30, 2017, the Company issued 122,500 shares of common stock to legal counsel for services in October 2017 valued at $8,575. On October 31, 2017, the Company issued 850,000 shares of common stock to Paul F. Pelosi, Jr. (“Pelosi”) valued at $26,285, in regard to his appointment as Chairman of the Board on November 1, 2017, for compensation for the period November 1, 2017 through January 31, 2018. The Company was obligated to issue on February 1, 2018, an additional 1,250,000 options for common stock with an exercise price of $0.04, with an expiration date eighteen months after issuance. On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in satisfaction of this obligation (see Note 13). The warrants have an exercise price of $0.04 and expire August 11, 2018. On October 25, 2017, the Company issued 250,000 shares of common stock to Frank Dobrucki for services in October 2017 valued at $7,725. On November 2, 2017, the Company issued 250,000 shares of common stock to Victor Park, a vendor, for services in October 2017 valued at $6,800. On November 3, 2017, the Company issued 1,006,768 shares of common stock to PureEnergy for the conversion of $15,475 of a convertible promissory note (see Note 11). On November 9, 2017, the Company issued 5,764,490 shares of common stock to Pure Energy for the conversion of $80,077 of principal and accrued interest of a convertible promissory note (see Note 11). On November 9, 2017, the Company sold 4,785,459 shares of common Stock to Pure Energy for $83,745.53, based on a per share price of $0.0175. On November 10, 2017, the Company sold 967,000 shares of common stock to Pelosi for $14,500, based on a per share price of $0.01499. On November 28, 2017, the Company issued 730,769 shares of common Stock to Michael Ostrander for services in October 2017 and November 2017. The shares for October 2017, which were effective October 1, 2017, were 500,000, whereas the shares for November 2017, which were effective November 1, 2017, were 230,769. The shares were valued at $40,119. On November 30, 2017, the Company recorded 600,000 shares of common stock as issuable to Alan Stone & Co. (“Stone”) in connection with various consulting services provided in 2017. The shares were valued at $29,400. On January 5, 2018 as amended on February 5, 2018, with an effective date of January 5, 2018, the Company consummated its previously-announced acquisition of 100% of the capital stock of Green Market Europe, S.L. (“GME”), a Spanish producer of hemp products. In partial consideration for the acquisition, the Company paid to GME’s seller 4,220,000 shares of the Company’s common stock valued at $295,400. On January 15, 2018, the Company issued to Stone 600,000 shares of common stock which were recorded as issuable as of December 31, 2017. On January 17, 2018, Pure Energy acquired 526,315 shares of the Company’s common stock for $25,000. On January 18, 2018, in connection with the Company’s appointment of Richard Groberg (“Groberg”) as its Chief Financial Officer to serve for an initial, two-year term, the Company (i) issued Groberg’s company, RSGroberg Consulting, LLC, 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. The common stock received was valued at $81,200 and $60,900, respectively. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it acquired from Power Up on January 17, 2018 and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total). The Power Up note, executed by the Company on July 20, 2017, had a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The common stock received was valued at $190,027 and resulted in the Company recording a loss of $157,340. On January 19, 2018, in conjunction with its conversion of that note, Pure Energy received 800,918 shares of common stock – (i) $19,826.19 in conjunction with the settlement amount owed by the Company to Power Up at the time Pure Energy acquired that note from Power Up in connection with that note, and (ii) $3,000 as a transaction fee ($22,826 in total). The common stock received was valued at $89,703 and resulted in the Company recording a loss of $66,877. On January 22, 2018, the Company issued 60,616 shares of common stock to Joseph Gurreri, an employee, in consideration of $8,550 of accrued wages. The common stock received had a value of $8,850 On January 22, 2018, Pelosi purchased 1,050,000 shares of common stock for $21,000. On January 22, 2018, the Company issued 82,192 shares of common stock to Steven Bloom in connection with consulting services provided in 2017 totaling $12,000. On January 22, 2018, the Company issued 16,952 shares of common stock to the Company’s legal counsel, in connection with services rendered totaling $2,475. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 (see Note 11) that the Company issued to Pure Energy on September 27, 2017 in conjunction with Pure Energy’s payoff of the May 10, 2017 Power Up convertible note. The common stock received was valued at $580,154 and resulted in the Company recording a loss of $558,722. On January 22, 2018, the Company issued Reliable Steel 229,671 shares of common stock for a portion of its debt of $33,532. On January 22, 2018, the Company issued 226,497 shares of common stock to Christopher Thompson, an employee, in connection with services provided in 2017 valued at $33,069. On January 5, 2018 and February, respectively the Company issued to Michael Ostrander: (i) 150,000 shares of common stock for services performed in December 2017 valued at $10,500, and (ii) 56,930 shares of common stock for services performed in January 2018 valued at $16,794. On January 31, 2018, the Company issued to Stone 600,000 shares of common stock which were recorded as issuable as of December 31, 2017. On January 31, 2018, the Company issued 122,466 shares of common stock to Christopher Sloan, a former employee of the Company, in connection with services rendered by him to the Company in 2017 totaling $39,740. On January 31, 2018, the Company issued 47,945 shares of common Stock to Lakeport Business Services, Inc. in connection with services rendered to the Company in 2018 valued at $7,000. The stock was valued at $15,558 based on the current stock price. On January 31, 2018, Pure Energy purchased 838,126 shares of common stock for $83,813. On February 7, 2018, Neil Dutson acquired 624,000 shares of common stock for $78,000. On February 7, 2018, Weintraub Law Group, LLC (“Weintraub”) surrendered 52,779 warrants at a value of $0.3048 per share, $16,090 in total, to effect the cashless exercise of warrants to acquire 215,378 shares of common stock at $0.06 per share. The Company had issued to Weintraub 268,167 warrants to acquire common stock and 268,167 shares of common stock on October 17, 2016 for the settlement of payables of $15,065. On February 9, 2018, Douglas Montgomery, Greg Montgomery and Lesley Montgomery acquired from the Company 160,000, 80,000 and 160,000, respectively, shares of the Company’s common stock, in each case for a purchase price of $0.125 per share, for total proceeds of $50,000. On February 21, 2018, the Company issued 83,760 shares of common Stock to Lakeport Business Services, Inc. in connection with services rendered to the Company in 2018 valued at 18,000 based on the current stock price. On March 6, 2018 Vincent Moreno acquired 500,000 shares of common stock for $50,000. On March 7, 2018, Neil Dutson acquired 909,090 shares of common stock for $100,000. On March 7, 2018, Esteemed Consultants acquired 909,091 shares of common stock for $100,000. On March 14, 2018, Rex Anthony Carrol acquired 272,727 shares of common stock for $30,000. On March 15, 2018, Vision Concepts acquired 74,074 shares for $10,000. In connection with its April 16, 2018 of Irie, effective April 1, 2018, the Company issued 8,118,886 shares of the Company’s common stock, valued at $998,62320, to Irie’s former owners. The purchase price is to be reduced if: (i) the Sellers’ aggregate pre-closing revenues for the year ending December 31, 2017, were less than $1,500,000 or (ii) the Buyer’s average monthly revenues resulting from the Acquisition of the Assets for the three months following closing are less than $120,000 per month. Additionally, 1,250,000 of the Shares were escrowed for four months following Closing as the Buyer’s security for: (i) any indemnification claims against the Sellers pursuant to the Agreement, or (ii) any pre-closing or post-closing revenue deficiency resulting in the purchase price reductions described above. In October 2018, the shares were released. On June 11, 2018, JRKH Investments, LLC purchased 54,745 shares of common stock of the Company for a purchase price of $0.091 per share, for total proceeds of $5,000. On April 2, 2018, the Company retained KSW Group, LLC as an independent contractor to render various services related to launching and managing various eCommerce initiatives for the Company. In connection with that appointment, the Company: (i) agreed to pay KSW monthly sales commissions based on net revenues generated by KSW, and (ii) issued to KSW 450,000 shares of the Company’s Rule 144 Common stock. The closing price of the Company’s common stock on the issuance date of April 2, 2018 was $0.135 per share. On April 3, 2018, Esteemed Consultants, Inc. acquired from the Company 1,000,000 shares of the Company’s common stock for a purchase price of $0.1775 per share, for total cash proceeds of $75,000. On April 11, 2018, Kahn Family Partnership purchased 4,444,444 shares of common stock of the Company for a purchase price of $0.09 per share, for total proceeds of $400,000. On that date, the Company also issued to Kahn Family Partnership a warrant to acquire 4,444,444 shares of common stock at an exercise price of $0.13 per share. The warrant expires on April 11, 2020. On April 30, 2018, the Company appointed Nevada State Senator Richard Segerblom as a member of the Company’s Board of Directors and issued to Senator Segerblom: (i) $50,000 in common stock to vest monthly for one year, with a value of $0.159 per share, for a total of 314,465 shares of common stock, and (ii) an eighteen-month warrant to acquire 500,000 shares of common stock at an exercise price of $0.10 per share. On April 30, 2018, with an effective date of April 1, 2018, the Company entered into separate consulting agreements with Karen Lane and Ricky Potts, each of whom were owners of and senior executives for Irie. Pursuant to these two agreements, each agreed to continue to provide senior management services relating to the operation of Irie under the ownership of the Company for at least nine months. In connection with these two agreements, the Company granted to each 500,000 shares of common stock of the Company, vesting monthly over a period of nine months, with the vesting beginning on the effective date. The shares were valued at $61,500 for each based on the closing price of the stock on the most recent trading day prior to April 1, 2018. The Company also agreed to a total monthly compensation to each of $4,000 per month, payable using the Company’s common stock. The determination of the number of shares of stock will be calculated monthly based on the average of the OTC closing price based on the last five trading days of each month, as applicable. On June 30, 2018, the Company issued to each of Karen Lane and Ricky Potts 67,545 shares of common stock, 135,090 shares in total, in connection with each’s engagement to manage Irie in consideration for which each agreed to monthly compensation to each of $4,000 payable at the end of each calendar quarter in the Company’s common stock with the determination of the number of shares of stock calculated monthly based on the average of the OTC closing price based on the last five day of each month shares are earned. On May 10, 2018, the Company appointed its CFO, Richard Groberg, as a member of the Company’s Board of Directors. In consideration of his appointment, the Company agreed to issue to Mr. Groberg’s entity: (1) $50,000 in common stock to vest monthly over a one-year period, at a value of $0.16 per share, for a total of 312,500 shares, and (2) an eighteen-month warrant to acquire 500,000 shares of common stock of the Company at an exercise price of $0.10 per share. On May 14, 2018, the Company sold 1,250,000 shares to each Caesar Capital Group (“Caesar”) and Joseph W. and Patricia G Abrams Family Trust dtd 3/95 (“Abrams”), 2,500,000 shares in total, for $200,000 in total consideration, based on a per share price of $0.08. On May 14, 2018, the Company issued to Caesar and Abrams 6,000,000 shares of the Company’s common stock (based on a value of $0.17 per share, or $995,400) in exchange for a 25% ownership interest in Cicero Transact Group, LLC (“Cicero”) Effective on June 1, 2018, the Company consummated a termination agreement with GME’s sellers in connection with GME’s sellers committed to return to the Company the 4,220,000 shares it previously issued to the sellers. Such shares have been cancelled. On June 21, 2018, the Company issued 312,500 of the Company’s common stock to Joseph Abrams, an individual acting as an independent contractor, to serve as a member of the Company’s Advisory. Such shares, valued at $0.16 per share or $54,844 in total, shall vest monthly over one year. On June 21, 2018, the Company issued 1,600,000 shares of common stock, at a value of $0.17 per share, or $264,160 subject to a leak-out agreement and a price adjustment if the average trading price of the Company’s common stock for the five days subsequent to the six-month anniversary of the consummation of this transaction does not exceed $0.25 per share, in connection with its acquisition of intellectual property relating (including an underlying patent pending application) to a proprietary formula for the compounding of a nutraceutical non-liquid to inhibit the accumulation of LDL cholesterol (and an underlying patent-pending application regarding the formula) developed by Healthy Discovery Associates Corp., a Florida corporation. On June 30, 2018, the Company issued to Kahn Family Trust 160,000 shares of common stock in connection with services rendered in June 2018 valued at $27,008. On June 30, 2018 the Company issued to each of Harvey Katz, Warm Family Revocable Trust and The Allan S. Kaplan Revocable Trust 50,000 shares of the Company's common stock, 150,000 shares in total, in connection with the appointment of each to the Company's advisory Board. Recipient Warm Family Revocable Trust directed the issuance of its 50,000 shares to Harvey Katz. Each issuance was valued at $8,440 based on the $0.17 closing price of the stock on June 29, 2018. On June 30, 2017, the Company issued 15,125 shares of common stock at $0.10 per share in consideration of $2,042 in compensation earned through March 31, 2018 to Marianne Luzzo, a consultant to the Company. On June 30, 2017, the Company issued 38,050 shares of common stock at $0.10 per share in consideration of $5,137 in compensation earned through March 31, 2018 to Silkia Ostrander, a consultant to the Company. On June 30, 2017 the Company issued 70,446 shares of common stock to Enrique Sempere, a consultant assisting the Company with its greenhouse operations in Valencia, for which he agreed to quarterly compensation of $12,500 payable at the end of each calendar quarter in the Company’s common stock and with the determination of the number of shares of stock calculated monthly based on the average of the OTC closing price based on the last five day of each month shares are earned. On June 30, 2018, the Company issued 500,000 shares of Common stock to Rodrigo Chavez, in connection with his April 1, 2018 engagement with the Company as a consultant. The shares vest 1/12 per month with the first vesting of April 30, 2018. The shares were valued at $67,500 based the closing price of $0.135 on the most recent trading day prior to April 1, 2018. On the same day the Company also issued 70,446 shares of common stock to Chavez valued at $12,505 in connection with April, May and June services rendered pursuant to his consulting engagement, for which he also agreed to monthly compensation of $4,167 in common stock with the determination of the number of shares of stock calculated monthly based on the average of the OTC closing price based on the last five day of each month shares are earned. On June 30, 2018, the Company issued 300,000 shares of common stock at $0.1688 to Ozzie Guzman in connection with his engagement by the Company in a consulting role valued at $50,640. On June 30, 2018, the Company issued 16,907 shares of common stock at $0.1688 to Trevor Hill, a consultant and former owner of Irie, in consideration of his services to the Company in those months valued at $1,000 per month, or $3,000 in total. On June 30, 2018, the Company issued 20,834 shares at $0.135 of common stock to Chris Thompson in consideration of consulting services he performed during the Company’s third fiscal quarter; (ii) 64,300 shares of common stock to Marianne Luzzo in consideration of consulting services she performed during the Company’s fourth fiscal quarter, and (iii) 53,684 shares of common stock to Silkia Ostrander in consideration of consulting services she performed during the Company’s fourth fiscal quarter valued at $9,907. As of June 30, 2018, 185,369,365 shares of common stock were outstanding. Warrants The following warrants were exercised during the fiscal year: On February 7, 2018, Weintraub Law Group, LLC (“Weintraub”) surrendered 52,779 warrants at a value of $0.3048 per share, $16,090 in total, to effect the cashless exercise of warrants to acquire 215,378 shares of common stock at $0.06 per share. The Company had issued to Weintraub 268,167 warrants to acquire common stock and 268,167 shares of common stock on October 17, 2016 for the settlement of payables of $15,065. The following warrants were cancelled during the fiscal year: On July 27, 2018, the Company agreed to sell to Paul T. Pelosi, Jr. 2,200,000 shares of the Company’s 144 common stock for the price of $38,500, $0.0175 per share, in consideration for which Pelosi agreed to: (1) cancellation and return of the previously issued to him and exercisable into 1,250,000 shares of Company common stock at $0.04 per share, and (2) the cancellation of the Company’s obligation to issue to him 850,000 shares of Company common stock. The following warrants expired during the fiscal year: A warrant to acquire 1,000,000 shares of common stock at $0.05 per share, issued in 2016 to Freedom Leaf Iberia, expired unexercised. A warrant to acquire 1,000,00 shares of common stock at $0.05 per share, issued in 2016 to Freedom Leaf Iberia, expired unexercised. For the year ended June 30, 2018, the Company issued the following warrants to acquire common stock: On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in lieu of a prior agreement for the Company to issue to Pelosi 1,250,000 options (see Note 12). The warrants have an exercise price of $0.04 and expire August 11, 2018. On April 11, 2018, the Company also issued to Kahn Family Partnership a warrant to acquire 4,444,444 shares of common stock at an exercise price of $0.13 per share. The warrant expires on April 11, 2020. On April 30, 2018, the Company appointed Nevada State Senator Richard Segerblom as a member of the Company’s Board of Directors and issued to Senator Segerblom an eighteen-month warrant to acquire 500,000 shares of common stock at an exercise price of $0.10 per share. On May 10, 2018, the Company appointed its CFO, Richard Groberg, as a member of the Company’s Board of Directors. In consideration of his appointment, the Company agreed to issue to Mr. Groberg’ s entity an eighteen-month warrant to acquire 500,000 shares of common stock of the Company at an exercise price of $0.10 per share. On May 15, 2018, the Company issued to Richard Cowan, a former director and related party, a warrant, exercisable between July 1, 2018 and November 15, 2019 at an exercise price of $0.01 per share, into 1,000,000 shares of Company common stock in connection with: (i) the Company’s issuance to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc magazine, as well as other “Freedom Leaf” branded merchandise and services. In consideration of such license and (ii) Cowan’s cancellation of $240,000 of payables owed to him by the Company. As of June 30, 2017, warrants to acquire 7,494,444 shares of common stock were outstanding. June 30, 2018 June 30 2017 Warrants Inception Date Expected volatility 260% 231% 193% - 261% Expected dividends – – – Expected term 2 - 9 months 21 months 0.25 - 1.76 Risk-free interest rate 1.93% 1.15% 0.98% - 1.82% A summary of the status of the options and warrants granted as at June 30, 2017 and 2016, and changes during the years then ended is presented below: Weighted- Weighted- Average Average Exercise Remaining Number of Price per Life Warrants Share (Years) Outstanding at June 30, 2017 4,618,167 Granted 7,694,444 $ 0.13 Exercised (268,167 ) $ 0.06 Cancelled (3,250,000 ) $ 0.05 Outstanding at June 30, 2018 8,794,444 $ 0.12 1.53 Exercisable at June 30, 2018 7,794,444 $ 0.10 1.73 A summary of the status of the warrants outstanding at June 30, 2018 is presented below: Range of Exercise Prices Number Outstanding Weighted-Average Remaining Contractual Life Number Exercisable Weighted-Average Exercise Price $0.01 – $0.09 2,200,000 1.89 years 2,200,000 $ 0.05 $0.01 – $0.09 5,594,444 1.66 years 5,594,444 $ 0.12 $0.01 – $0.09 1,000,000 – – – $0.01 – $0.29 8,794,444 1.53 years 7,794,444 $ 0.10 Stock Option Plan On June 27, 2016, the Board of Directors approved the 2016 Stock Option Plan which has reserved 10,000,000 shares of common stock.

9. Revenue Classes

9. Revenue Classes	12 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
Revenue Classes	NOTE 9 – REVENUE CLASSES Selected financial information for the Company’s operating revenue classes as of June 30, 2018 and 2017, are as follows: For the years ended Revenues: June 30, 2018 2017 Magazine related $ 9,484 $ 39,161 Referral fees – 10,054 Licensing fees – 750,000 Product sales 401,788 – Equipment sales commissions – 18,242 Total $ 411,272 $ 817,457 For the years ended Direct costs of revenue: June 30, 2018 2017 Magazine related $ 89,518 $ 124,290 Referral fees – – Licensing fees – – Product sales 211,695 – Equipment sales commissions – – Total $ 311,213 $ 124,290 The Company’s four revenue classes are magazine related, referral fees, licensing fees (see Note 2), product sales and equipment sales commissions (see Note 2).

10. Income Tax

10. Income Tax	12 Months Ended
	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Income Tax	NOTE 10 – INCOME TAX As of June 30, 2018, and 2017, the Company has net operating loss carry forwards of $4,594,669 and $3,196,453, respectively. The carry forwards expire through the year 2038. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code. The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% to loss before taxes for year 2018 and 34% to loss before taxes for fiscal year 2017), as follows: For the Years Ended June 30, 2018 2017 Tax expense (benefit) at the statutory rate $ 972,021 $ (309,621 ) State income taxes, net of federal income tax benefit – (134 ) Change in valuation allowance (972,021 ) 309,755 Total $ – $ – The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities. The tax years 2014 through 2018 remain subject to examination by federal agencies and other jurisdictions in which it operates. The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2018 and 2017, respectively, are as follows: June 30, 2018 2017 Deferred tax assets: Net operating loss carryforward $ 1,398,216 $ 1,073,183 Timing differences 906,968 908,366 Total gross deferred tax assets 2,305,184 1,981,549 Less: Deferred tax asset valuation allowance (2,305,184 ) (1,981,549 ) Total net deferred taxes $ – $ – In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Because of the historical earnings history of the Company, the net deferred tax assets for 2018 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $2,305,184 and $1,981,549 as of June 30, 2018 and 2017, respectively.

11. Concentrations

11. Concentrations	12 Months Ended
	Jun. 30, 2018
Risks and Uncertainties [Abstract]
Concentrations	NOTE 11 – CONCENTRATIONS Concentration of Credit Risk Financial instruments, which potentially subject the Company to a concentration of credit risk, consist principally of temporary cash investments. The Company places its temporary cash investments with financial institutions insured by the FDIC. No amounts exceeded federally insured limits as of June 30, 2018. There have been no losses in these accounts through June 30, 2018. Concentration of Revenue In 2018, the Company had six customers that made up 64.9% or more of its revenue. In 2017, the Company had three customers that made up 90.3% of its revenue. Concentration of Supplier The Company does not rely on any particular suppliers for its services. Concentration of Intellectual Property The Company owns or has filed for the trademarks “Freedom Leaf,” “Hemp Inspired,” “Cannabizu,” and “Cannabiz” as filed with the United States Patent and Trademark Office. The Company has filed for “Freedom Leaf” in Jamaica and Uruguay.

12. Other Receivables

12. Other Receivables	12 Months Ended
	Jun. 30, 2018
Receivables [Abstract]
Other Receivables	NOTE 12 – OTHER RECEIVABLES The Company has three licensing agreements with the following: FLNL, FLI and BBDHS (see Note 2). The net present value, per entity, as would be recorded in Other Receivables, was written off in fiscal year 2018.

13. Intangible Assets

13. Intangible Assets	12 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 13 – INTANGIBLE ASSETS Intangible assets at June 30, 2018 and 2017 consisted of the following: June 30, 2018 June 30, 2017 Websites and other intangible assets $ 519,923 $ 12,245 Trademarks and trade names 342,682 – Customer relationships 712,000 – Patents and intellectual property 264,160 – Total intangible assets 1,838,765 12,245 Accumulated amortization (316,191 ) (1,425 ) Intangible assets, net $ 1,522,574 $ 10,820 The amortization expense for the years ended August 31, 2018 and 2017, was $332,964 and $741, respectively. The following table presents the amortization for the next five years: 2018 $ 691,788 2019 477,884 2020 148,603 2021 89,165 2022 and thereafter 115,134 Total $ 1,522,574

14. Derivatives

14. Derivatives	12 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	NOTE 14 – DERIVATIVES Embedded Conversion Option Derivatives Due to the conversion terms of certain promissory notes (see Note 7), the embedded conversion options met the criteria to be bifurcated and presented as derivative liabilities. The Company calculated the estimated fair values of the liabilities for embedded conversion option derivative instruments at the original note inception date and as of June 30, 2018 using the Black-Scholes option pricing model using the share prices of the Company’s stock on the dates of valuation and using the following ranges for volatility, expected term and the risk-free interest rate at each respective valuation date, no dividend has been assumed for any of the periods: Note Inception Date June 30, 2018 Volatility 170% - 232% 0% Expected Term 0.75 - 0.83 years 0 years Risk Free Interest Rate 1.07% - 1.18% 0.00% The following reflects the initial fair value on the note inception date and changes in fair value through June 30, 2018: Note inception date fair value allocated to debt discount $ 122,500 Change in fair value in 2016 (122,500 ) Embedded conversion option derivative liability fair value on June 30, 2016 – Note inception date fair value allocated to debt discount 163,000 Note modifications adjustment (54,927 ) Change in fair value in 2017 (55,316 ) Embedded conversion option derivative liability fair value on June 30, 2017 52,757 Note inception date fair value allocated to debt discount 118,228 Change in fair value in 2018 (170,985 ) Embedded conversion option derivative liability fair value on June 30, 2018 $ –

15. Inventory

15. Inventory	12 Months Ended
	Jun. 30, 2018
Inventory Disclosure [Abstract]
Inventory	NOTE 15 – INVENTORY Inventories at June 30, 2018 and 2017 consisted of the following: June 30, June 30, 2018 2017 Work in process $ 126,047 $ – Finished goods 111,681 – Allowance for inventory obsolescence (36,039 ) – Total inventory $ 201,689 $ –

16. Property And Equipment

16. Property And Equipment	12 Months Ended
	Jun. 30, 2018
Property, Plant and Equipment [Abstract]
Property And Equipment	NOTE 16 – PROPERTY AND EQUIPMENT Property and equipment June 30, 2018 and 2017 consisted of the following: June 30, 2018 2017 Property and equipment $ 1,874,480 $ – Furniture and office equipment 173,500 – Land 630,805 – Building 2,170,963 – Total fixed assets 4,849,748 – Accumulated depreciation (63,698 ) – Total fixed assets, net $ 4,786,050 $ – Depreciation expense for the years ended June 30, 2018 and 2017 was $63,698 and $-0-, respectively.

17. Investments

17. Investments	12 Months Ended
	Jun. 30, 2018
Investments Schedule [Abstract]
Investments	NOTE 17 – INVESTMENTS On January 18, 2016, the Company and Plants to Paper, LLC (“PTP”), a New Jersey limited liability company, executed an Incubation Agreement. PTP owned the patent pending application 62/245,153 (the “Patent”) with the title being “Rolling Papers and Blunt Wraps made from 100% Marijuana.” PTP agreed to transfer its ownership rights in the patent application to the Company, as well as PTP’s Medical Marijuana / Cannabis/Hemp Industry Incubator program. The Company agreed to supply management services and to fund the early stage development of PTP. The Incubation Agreement was for a period of twelve months. PTP will provide the Company with 20% of the outstanding membership shares of PTP in exchange for its services. The costs of patent registrations in the United States and other countries will be the liability of PTP. On February 1, 2017, the Agreement was modified for the following items: a) to provide 25% of the outstanding membership shares of PTP; b) require that the Patent be assigned to PTP; and c) acknowledge that the ownership rights have not been transferred to the Company as of that date. To date, ownership rights have not been transferred. This agreement expired on January 18, 2017. The Company made no investment in PTP and recorded no investment in that entity. The Company has investments of $995,400 and $0 at June 30, 2018 and 2017, respectively. The investment at June 30, 2018 relates to the 25% investment in Cicero Transact Group, LLC, a company that is launching an innovative, online business-to-business deal platform. As of June 30, 2018, Cicero Transact Group, LLC had incurred nominal expenditures and had generated no revenues. Its formal development efforts commenced in July 2018. See Notes 8 and 18.

18. Subsequent Events

18. Subsequent Events	12 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	NOTE 18 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued and filed with the Securities and Exchange Commission. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein. On July 12, 2018, the Company sold 560,000 shares of common stock to Vista Capital Investment, LLC at a per share price of $0.125, or total proceeds of $70,000. On July 16, 2018, the Company issued 33,085 shares of common stock (vesting 1/12 per month with first vesting on July 31, 2018), at an aggregate value of $5,000 to Laurence Ruhe in partial consideration of his employment with the Company. On July 18, 2018, the Company issued 40,178 shares of S-8 common stock valued at that day’s closing price of $0.129425 to Lakeport Business Services in consideration for accounting services. On July 2, 2018 the Company issued 240,00 shares of common stock valued at $36,000 based on the closing price on that day of $0.15 and vesting 1/12 per month with first vesting on July 31, 2018, to Richard Bolandz in connection with his consulting engagement with the Company. The Company, on July 15, 2108 sold 1,500,000 shares of the Company’s common stock to Neil Dutson at $0.1166 per share for which he: (i) paid the Company $50,000 in cash and (ii) granted to the Company of an option on the 5-acre property in North Vegas valued at $125,000. If exercised, the option, exercisable for four months, will apply toward a down payment total of $625,000 toward the total purchase price of $1,625,000 to acquire a parcel of land in North Las Vegas that the Company seeks to acquire and build out for various operating and corporate uses. In connection with the exercise of the option and purchase of the land, Dutson has agreed to hold a mortgage of $1,000,000 million payable in eight quarterly installments of principal plus interest at 8.0%, in either (at the Company’s option): (i) cash or (ii) Company common stock (at the lower of: (a) VWAP for prior 5 days or (b) $0.25). On July 27, 2018, the Company sold 2,200,000 shares of common stock for the price of $38,500, $0.0175 per share to Paul T. Pelosi Jr in partial consideration for which Pelosi: (i) cancelled and returned to the Company a Warrant previously issued to him and exercisable into 1,250,000 shares of Company common stock at $0.04 per share and (ii) permitted the cancellation of the Company’s obligation to issue to him 850,000 shares of Company common stock originally granted to him in connection with his appointment as the Company’s Board Chairman on October 31, 2017. On July 17, 2018, the Company sold 100,000 shares, 200,000 shares in total, for the total price of $25,000, $0.125 per share, to each of Messers. Michael Woloshin & Joseph Abrams. On July 26, 2018, the Company issued 3,000,000 Shares of the common stock valued at $750,000, or $0.25 cents per share with a true-up in six months, to Messers. Michael Woloshin & Joseph Abrams (existing stockholders and owners of the Company’s 25%-owned Cicero Transact Group, LLC) On July 26, 2018, the Company acquired 100% of the membership interests of Tierra Science Global, LLC (“Tierra Science Global”), a nutraceutical business, for which it: (i) issued to that Company’s owners 2,000,000 shares of the Company’s common stock, valued at $246,000 based on the closing price of the common stock on that day and (ii) entered into employment agreements with the Company’s principal executives. Tierra formed in August of 2017has generated sales during calendar 2018 to-date of approximately $400,000. The Company intends to expand Tierra’s product offering to include various cannabidiol products branded as “powered by Freedom Leaf. On August 2, 2018, the Company issued 35,550 shares of common stock at an agreed price per share of $0.10 per share, to Jonathan Rathmann in consideration of $3,550 of services provided. On August 3, 2018 the Company sold 121,212 shares of common stock to Robbie Rosenfeld at $0 .0825 per share, or $10,000 in total. On August 3, 2018 the Company sold 121,212 shares of common stock to Karen Lane at $0 .0825 per share, or $10,000 in total. On July 31, 2018, the Company issued 41,855 shares of common stock at a price per share of $0.119, based on the average closing price the last five trading days of July, in consideration of consulting services provided by Richard Bolandz valued at $5,000. On July 31, 2018, the company issued 406,393 shares of common stock, at a price per share of $0.119, based on the average closing price the last five trading days of July, to Reliable Steel in consideration of open invoices from services provided through calendar 2018 to date totaling $48,360.79. On July 30, 2018, the Company issued 8,403 shares of common stock at prices ranging from $0.163 to $0.179, based on the average closing price the last five days of July 2018 to Trevor Hill, a consultant and former owner of Irie, in consideration of his services to the Company in July valued at $1,000 per month. On August 14, 2018, the Company issued 34,630 shares of common stock, at an agreed price per share of $0.135 per share, to Lance Brunson in consideration of $4,675 of legal services provided. On August 20, 2018, the Company issued 17,361 shares of common stock, at an agreed price of $0.12 per share, to Enrique Sempere in consideration of $2,083.33 of services provided. On September 3, 2017 the Company issued 62,972 and 61,207 shares of common stock, respectively, (124,179 shares in total) to NuAxon BioScience, Inc. in consideration of $10,000 per month of April and May 2018 consulting services. Both issuances were based on the average closing price of the stock the last five trading days of the respective month. On September 5, 2018, the Company, and a cannabis-focused Private Equity Fund, Merida Capital Partners II, LP, (the “ Merida Deposit Amount Term Sheet Reference Date Purchased Shares VWAP Securities Purchase Agreement Investors th Purchase Price Common Shares Warrants Bonus Warrants Commission On September 24, 2018, the Company issues 37,392 shares of common stock, at a price per share of $0.15, based on the closing price on that day, to Mark Newbauer in consideration of open invoices from various public relations services provided through in July and August of 2018 totaling $6,050.

1. Nature of Operations and S_2

1. Nature of Operations and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization The Company was incorporated in the State of Nevada on February 21, 2013, under the name of Arkadia International, Inc. The Company was originally engaged in the business of the acquisition of in demand equipment, cars, and goods with the intent to resell these in the U.S. territories or export to overseas countries. On October 3, 2014, the Company experienced a change in control. Richard C. Cowan acquired approximately 93% of the issued and outstanding common stock of the Company at the time. On November 6, 2014, the Company merged with Freedom Leaf Inc., a private Nevada corporation, and the Company changed its name to Freedom Leaf Inc. In connection with the merger, the sole officer, director and stockholder of the private company, Clifford J. Perry, became an officer and director of the Company, and Mr. Perry received approximately 48.1% of the Company’s common stock post-merger. For financial reporting purposes, this merger was accounted for as a "reverse acquisition" rather than a business combination, and the private company was deemed to be the accounting acquirer in the transaction, with the Company deemed to be the acquired company for financial reporting purposes. Consequently, the assets and liabilities and the operations that were reflected in the historical financial statements of the Company prior to the merger are those of the private company, and they were recorded at the historical cost basis of the private company, and the financial statements after completion of the merger include the combined assets and liabilities of the Company and the private company, the historical operations of the private company only, and the operations of both companies from the closing date of the merger. Freedom Leaf Inc. is an audited and reporting public company traded under the symbol (OTCQB: FRLF) with corporate headquarters located at 3571 E. Sunset Road, Las Vegas, Nevada, 89120. Subsidiary Entities: · Cannabis Business Solutions Inc. (“Cannabis Business Solutions”), a Nevada corporation, was formed on February 5, 2014, and is a wholly-owned subsidiary of the Company. This subsidiary had no activity until the agreement with Valencia Web Technology S.L., B-97183354 (see Note 2). · Leafceuticals Inc. (“Leafceuticals”), formerly known as Cannabiz U, Inc., a Nevada corporation, was formed on February 13, 2014, and is a wholly-owned subsidiary of the Company. · Freedom Leaf International Inc. (“Freedom Leaf International”), a Nevada corporation, was formed on November 27, 2015, and is a wholly-owned subsidiary of the Company. This subsidiary has had no activity to date. · Leafceuticals Europe, SL, a wholly-owned subsidiary of the Company’s owns our Valencia greenhouse operations. · Freedom Leaf Cares Inc. (“Freedom Leaf Cares”), a Nevada corporation, was formed on October 1, 2014, and is a wholly-owned subsidiary of the Company. Freedom Leaf Cares was dissolved in 2016. Until dissolution, this subsidiary had no activity.
Nature of Operations	Nature of Operations Freedom Leaf Inc. is a group of diversified, multinational, vertically-integrated hemp businesses and cannabis media companies. Freedom Leaf has strived to be a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industries since 2014, founded by professionals with Decades of combined experience in cannabis legalization advocacy. The Company is continuously building a diverse, global portfolio of valuable businesses and enterprises through strategic mergers, acquisitions, and acceleration projects across the hemp and cannabis industry. Utilizing these mergers and acquisitions, Freedom Leaf is building a solid foundation for our vertically-integrated hemp company to maximize both stockholder value and revenue growth. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp extract, which allows dramatically lower production costs for our wholly-owned hemp product lines, thereby generating more revenue for each product sold. We also formulate and manufacture the majority of our products in our own in-house formulation centers, also greatly reducing our costs and increasing revenue. In addition, our extensive domestic and international media companies ensure we can continuously direct traffic to our many ecommerce sites and nationwide retail locations. For valuation purposes, the Company’s focus is on developing and implementing multiple, mutually-reinforcing revenue streams; through which revenue, net income and stockholder value are maximized by cross-marketing across its brands and advertising through its media properties. The Company’s major business lines are: · Legal Industrial Hemp Cultivation · Cannabidiol Extraction, Distillation, and Processing · Expert Product Formulation · Nutraceutical Brand Marketing · Ancillary Products & Niche Markets · Affiliate Marketing Programs · E-Commerce Solutions · Global Media & Advertising Networks
Basis of Presentation	Basis of Presentation The Company prepares its consolidated financial statements in conformity with generally accepted accounting principles in the United States of America.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Freedom Leaf and its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The Company consolidates any variable interest entities of which it is the primary beneficiary. Equity investments through which the Company exercises significant influence over but does not control the investee and is not the primary beneficiary of the investee’s activities are accounted for using the equity method. Investments through which the Company is not able to exercise significant influence over the investee and which do not have readily determinable fair values are accounted for under the cost method. All material inter-company accounts have been eliminated in the consolidation.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company accounts for long-lived assets in accordance with the provisions of Statement of Financial Accounting Standards ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities. We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. We currently measure and report at fair value derivative liabilities. The fair value of derivative liabilities is measured using the Black-Scholes option pricing method. The following table summarizes our non-financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2018 and 2017: The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis at June 30, 2018: Balance at Quoted Prices Significant Significant (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ – $ – $ – $ – Total Financial Liabilities $ – $ – $ – $ – The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis at June 30, 2017: Balance at June 30, 2017 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ 52,757 $ – $ – $ 52,757 Total Financial Liabilities $ 52,757 $ – $ – $ 52,757 Following is a summary of activity through June 30, 2018 of the fair value of derivative liabilities valued using Level 3 inputs: Balance at June 30, 2017 $ 52,757 Note inception date fair value 6,370 Change in fair value during 2018 (59,127 ) Balance at June 30, 2018 $ –
Stock-based Compensation	Stock-Based Compensation The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition provisions ASC Topic 505-50. The Company estimates the fair value of stock options at the grant date by using the Black-Scholes option-pricing model.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.
Reclassifications	Reclassifications Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders’ equity as previously reported.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
Accounts Receivable	Accounts Receivable Accounts receivable consisted of amounts due from customers primarily for management fees. The Company considered accounts more than 30 days old to be past due. The Company used the allowance method for recognizing bad debts. When an account was deemed uncollectible, it was written off against the allowance. The Company generally does not require collateral for its accounts receivable. Management has recorded an allowance for doubtful accounts as of June 30, 2018 of $20,261 and $0 as of June 30, 2017.
Inventory	Inventory Inventory is recorded at the lower of cost or market and the cost of sales are recorded utilizing the first in first out (“FIFO”) method. The Company periodically evaluates the value of items in inventory and provides write-downs to inventory based on its estimate of market conditions. The Company estimated it needed an obsolescence allowance of $36,039 and $0 for the years ended June 30, 2018 and 2017, respectively, which was charged to cost of goods sold.
Investments	Investments The Company uses the cost method to account for investments in businesses that are not publicly traded and for which the Company does not control or have the ability to exercise significant influence over operating and financial policies. In accordance with the cost method, these investments are recorded at lower of cost or fair value, as appropriate, and are classified as long-term. Under this method, the Company’s share of the earnings or losses of such investee companies is not included in the consolidated balance sheet or consolidated statements of operations and comprehensive income or loss. However, impairment charges are recognized in the consolidated statements of operations and comprehensive income or loss. If circumstances suggest that the value of the investee company has subsequently recovered, such recovery is not recorded. Investments held by the Company in businesses that are not publicly traded and for which the Company has the ability to exercise significant influence over operating and financial management are accounted for under the equity method. In accordance with the equity method, these investments are originally recorded at cost and are adjusted for the Company’s proportionate share of earnings, losses and distributions. The Company holds no such investments as of June 30, 2018 or 2017. The Company assesses and records impairment losses when events and circumstances indicate the investments might be impaired. Gains and losses are recognized when realized and recorded in other income (expense) in the accompanying Consolidated Statements of Operations and Comprehensive Loss.
Property, Equipment and Depreciation	Property, Equipment and Depreciation Property and equipment is recorded at cost. Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets of three years for computer equipment, five years for office furniture and fixtures, five years for machinery and equipment, thirty-nine years for buildings, and the lesser of the lease term or the useful life of the leased equipment. Leasehold improvements, if any, would be amortized over the lesser of the lease term or the useful life of the improvements. Expenditures for maintenance and repairs along with fixed assets below our capitalization threshold are expensed as incurred. Variances between the two reporting periods are primarily due to foreign currency translation calculations.
Goodwill	Goodwill Goodwill and Intangible Assets In applying the acquisition method of accounting, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Identifiable intangible assets are initially valued at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Identifiable intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment within one year of acquisitions or annually as of March 31, and whenever indicators of impairment exist. The fair values of intangible assets are compared with their carrying values, and an impairment loss would be recognized for the amount by which a carrying amount exceeds its fair value. Goodwill is reviewed for impairment annually, and more frequently as circumstances warrant, and written down only in the period in which the recorded value of such assets exceeds their fair value. The Company does not amortize goodwill in accordance with Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 350, "Intangibles—Goodwill and Other" ("ASC 350"). Goodwill is tested for impairment at the reporting unit level. The Company's two operating segments comprise the reporting unit for goodwill impairment testing purposes. The amortization of the intangible assets is computed using the straight-line method based on the estimated useful lives of the related assets of three years for website development, fifteen years for trademarks, one year for exclusive rights, nine years for trade names, two years for customer lists, one year for assembled workforce, and five years for patent. Variances between the two reporting periods are primarily due to foreign currency translation calculations.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date.
Revenue Recognition	Revenue Recognition The Company recognizes revenue for our services in accordance with ASC 605-10, "Revenue Recognition in Financial Statements." Under these guidelines, revenue is recognized on transactions when all of the following exist: persuasive evidence of an arrangement did exist, delivery of service has occurred, the sales price to the buyer is fixed or determinable and collectability is reasonably assured. The Company has five primary revenue streams as follows: · Advertising Services – Revenue from advertising is recognized over the contracted period in which advertising services are performed. Advertising services are considered performed when an ad is displayed to users. · Product Sales – Revenue from the sale of the Company’s branded products is recognized in the period in which product is shipped. Sales billed or cash received in advance of actual shipment are deferred and recorded as income in the period in which shipment is made. Shipping and handling fees billed to customers is included in net sales. Shipping and handling costs are expensed as incurred and included in cost of sales. All sales are presented net of sales taxes, which are excluded from revenue. · Licensing Revenue – Revenue from licensing arrangements is recognized when earned, estimable and realizable. The timing of revenue recognition is dependent on the terms of each license agreement and on the timing of sales of licensed products. The Company generally recognizes royalty revenue when it is reported to the Company by its licensees, which is generally one quarter in arrears from the licensees’ sales of licensed products. For licensing fees that are not determined by the licensees’ sales, the Company generally recognizes license fee revenue on a straight-line basis over the life of the license.
Advertising and Marketing	Advertising and Marketing Advertising and marketing is expensed as incurred and is included in selling, general and administrative expenses on the accompanying statement of operations. For the years ended June 30, 2018 and 2017, advertising expense was $49,656 and $41,712, respectively.
Income Taxes	Income Taxes The Company adopted the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for unrecognized tax benefits. As of June 30, 2018, all previous tax years remain open for IRS audit. The Company has received no notice of audit from the IRS for any of the open tax years. The Company adopted ASC 740-10, “
Net Earnings (Loss) Per Share	Net Earnings (Loss) Per Share In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares that may dilute future earnings per share consist of warrants to purchase 4,518,167 shares of common stock at June 30, 2018. Equivalent shares are not utilized when the effect is anti-dilutive.
Foreign Currency Translation and Transactions	Foreign Currency Translation and Transactions The Euro (“EUR,” or “€”) is the functional currency of Green Market Europe, S.L. and Leafceuticals Europe S.L.U., whereas the consolidated financial statements are reported in United States Dollar (“USD,” or “$”). Assets and liabilities are translated based on the exchange rates at the balance sheet date, while revenue and expense accounts are translated at the average exchange rates prevailing during the period. Equity accounts are translated at historical exchange rates. The resulting translation gain and loss adjustments are accumulated as a component of stockholders’ equity and other comprehensive income.
Comprehensive Income (Loss)	Comprehensive Income (Loss) The Company reports comprehensive income (loss) and its components in its consolidated financial statements. Comprehensive income (loss) consists of net loss and foreign currency translation adjustments affecting stockholders’ equity that, under U.S. GAAP, are excluded from net loss. As of June 30, 2018, the exchange rate between U.S. Dollars and the Euro was USD $1.17 = €1.00, and the weighted average exchange rate for the period (acquisition date to end of fiscal year) ended June 30, 2018 was USD $1.20 = €1.00.
Segment Information	Segment Information In accordance with the provisions of ASC 280-10, “Disclosures about Segments of an Enterprise and Related Information”, the Company is required to report financial and descriptive information about its reportable operating segments. The Company does not have any operating segments as of June 30, 2018 and 2017.
Effect of Recent Accounting Pronouncements	Effect of Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (“ASC 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method, nor has it determined the effect of the standard on its ongoing financial reporting. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In February 2016, the Financial Accounting Standards Board (“FASB”) issued an ASU on lease accounting. The ASU requires the lease rights and obligations arising from lease contracts, including existing and new arrangements, to be recognized as assets and liabilities on the balance sheet. The ASU is effective for reporting periods beginning after December 15, 2018 with early adoption permitted. While the Company is still evaluating the ASU, the Company expects the adoption of the ASU to have a material effect on the Company’s financial condition due to the recognition of the lease rights and obligations as assets and liabilities. The Company does not expect the ASU to have a material effect on the Company’s results of operations, and the ASU will have no effect on cash flows. The Company has evaluated all other recent accounting pronouncements and believes that none of them will have a significant effect on the Company’s financial statement.

1. Nature of Operations and S_3

1. Nature of Operations and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of financial liabilities on a recurring basis	Balance at June 30, 2018 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ – $ – $ – $ – Total Financial Liabilities $ – $ – $ – $ – Balance at June 30, 2017 Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Liabilities: Derivative Liabilities $ 52,757 $ – $ – $ 52,757 Total Financial Liabilities $ 52,757 $ – $ – $ 52,757
Schedule of activity of fair value of derivatives	Balance at June 30, 2017 $ 52,757 Note inception date fair value 6,370 Change in fair value during 2018 (59,127 ) Balance at June 30, 2018 $ –

3. Business Combination (Tables

3. Business Combination (Tables)	12 Months Ended
	Jun. 30, 2018
Irie [Member]
Allocation of assets acquired and liabilities assumed in business combination	Consideration given: Cash Consideration $ 356,000 Common stock shares given 999,000 Notes Assumed 100,000 Total consideration given $ 1,455,000 Fair value of identifiable assets acquired, and liabilities assumed: Current Assets $ 226,000 Current Liabilities 44,000 Net Working Capital 182,000 Property, Plant & Equipment 25,000 Trade Names/Trademarks 327,000 Customer Contracts/Relationships 712,000 Assembled Workforce 139,000 Goodwill 70,000 Total Consideration $ 1,455,000
Proforma information	For the Year Ended June 30, 2018 Revenues, net $ 1,629,730 Net loss allocable to common stockholders (305,757 ) Net loss per common share $ (0.00 ) Weighted-average number of share outstanding 149,199,226
Green Market [Member]
Allocation of assets acquired and liabilities assumed in business combination	Consideration given: Common stock shares given $ 295,400 Total consideration given $ 295,400 Fair value of identifiable assets acquired, and liabilities assumed: Cash $ 3,546 Accounts receivable 7,430 Fixed assets, net 64,891 Intangible assets, net 5,176 Accounts payable (71,478 ) Acquisition payable (24,805 ) Payable to stockholders (5,045 ) Total identifiable net liabilities (20,285 ) Goodwill 315,685 Total consideration $ 295,400

5. Commitments and Contingenc_2

5. Commitments and Contingencies (Tables)	12 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Future minimum lease payments	2019 $ 29,646 Total $ 29,646 2019 $ 40,700 Total $ 40,700

7. Convertible Notes Payable,_2

7. Convertible Notes Payable, Net of Premiums and Notes Payable (Tables)	12 Months Ended
	Jun. 30, 2018
Debt Disclosure [Abstract]
Schedule of convertible notes	Convertible notes, net of discounts and notes payable June 30, 2018 June 30, 2017 Principal Principal, Debt net of Debt net of Principal Discounts Discounts Principal Discounts Discounts Baytown Holdings (b) $ 95,000 $ – 95,000 $ – $ – $ – Valencia (c) 4,629,486 – 4,629,486 – – – Irie (c) 99,000 – 99,000 – – – Pure Energy (a)(b) – – – 15,475 (7,489 ) 7,986 Pure Energy (a)(b) – – – 13,480 (5,565 ) 7,915 Power Up (a)(b) – – – 75,000 (39,330 ) 35,670 Power Up (a)(b) – – – 38,000 (18,893 ) 19,107 Total $ 4,832,486 $ – $ 4,832,486 $ 141,955 $ (71,277 ) $ 70,678 Short-term notes payable (95,000 ) – (95,000 ) - - - Current portion of long-term notes payable (286,575 ) – (286,575 ) - - - Long-term portion $ 4,441,911 $ – $ 4,441,911 $ 141,955 $ (71,277 ) $ 70,678 (a) Convertible (b) Short-term (c) Long-term

8. Stockholders' Equity (Tables

8. Stockholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2018
Equity [Abstract]
Schedule of Assumptions	June 30, 2018 June 30 2017 Warrants Inception Date Expected volatility 260% 231% 193% - 261% Expected dividends – – – Expected term 2 - 9 months 21 months 0.25 - 1.76 Risk-free interest rate 1.93% 1.15% 0.98% - 1.82%
Schedule of warrants	Weighted- Weighted- Average Average Exercise Remaining Number of Price per Life Warrants Share (Years) Outstanding at June 30, 2017 4,618,167 Granted 7,694,444 $ 0.13 Exercised (268,167 ) $ 0.06 Cancelled (3,250,000 ) $ 0.05 Outstanding at June 30, 2018 8,794,444 $ 0.12 1.53 Exercisable at June 30, 2018 7,794,444 $ 0.10 1.73
Summary of warrants outstanding	Range of Exercise Prices Number Outstanding Weighted-Average Remaining Contractual Life Number Exercisable Weighted-Average Exercise Price $0.01 – $0.09 2,200,000 1.89 years 2,200,000 $ 0.05 $0.01 – $0.09 5,594,444 1.66 years 5,594,444 $ 0.12 $0.01 – $0.09 1,000,000 – – – $0.01 – $0.29 8,794,444 1.53 years 7,794,444 $ 0.10

9. Revenue Classes (Tables)

9. Revenue Classes (Tables)	12 Months Ended
	Jun. 30, 2018
Segment Reporting [Abstract]
Revenues and Costs by revenue class	For the years ended Revenues: June 30, 2018 2017 Magazine related $ 9,484 $ 39,161 Referral fees – 10,054 Licensing fees – 750,000 Product sales 401,788 – Equipment sales commissions – 18,242 Total $ 411,272 $ 817,457 For the years ended Direct costs of revenue: June 30, 2018 2017 Magazine related $ 89,518 $ 124,290 Referral fees – – Licensing fees – – Product sales 211,695 – Equipment sales commissions – – Total $ 311,213 $ 124,290

10. Income Tax (Tables)

10. Income Tax (Tables)	12 Months Ended
	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Income tax provision schedule	For the Years Ended June 30, 2018 2017 Tax expense (benefit) at the statutory rate $ 972,021 $ (309,621 ) State income taxes, net of federal income tax benefit – (134 ) Change in valuation allowance (972,021 ) 309,755 Total $ – $ –
Schedule of deferred taxes	June 30, 2018 2017 Deferred tax assets: Net operating loss carryforward $ 1,398,216 $ 1,073,183 Timing differences 906,968 908,366 Total gross deferred tax assets 2,305,184 1,981,549 Less: Deferred tax asset valuation allowance (2,305,184 ) (1,981,549 ) Total net deferred taxes $ – $ –

13. Intangible Assets (Tables)

13. Intangible Assets (Tables)	12 Months Ended
	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	June 30, 2018 June 30, 2017 Websites and other intangible assets $ 519,923 $ 12,245 Trademarks and trade names 342,682 – Customer relationships 712,000 – Patents and intellectual property 264,160 – Total intangible assets 1,838,765 12,245 Accumulated amortization (316,191 ) (1,425 ) Intangible assets, net $ 1,522,574 $ 10,820
Amortization table	2018 $ 691,788 2019 477,884 2020 148,603 2021 89,165 2022 and thereafter 115,134 Total $ 1,522,574

14. Derivatives (Tables)

14. Derivatives (Tables)	12 Months Ended
	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Assumptions	Note Inception Date June 30, 2018 Volatility 170% - 232% 0% Expected Term 0.75 - 0.83 years 0 years Risk Free Interest Rate 1.07% - 1.18% 0.00%
Schedule of derivative instruments	Note inception date fair value allocated to debt discount $ 122,500 Change in fair value in 2016 (122,500 ) Embedded conversion option derivative liability fair value on June 30, 2016 – Note inception date fair value allocated to debt discount 163,000 Note modifications adjustment (54,927 ) Change in fair value in 2017 (55,316 ) Embedded conversion option derivative liability fair value on June 30, 2017 52,757 Note inception date fair value allocated to debt discount 118,228 Change in fair value in 2018 (170,985 ) Embedded conversion option derivative liability fair value on June 30, 2018 $ –

15. Inventory (Tables)

15. Inventory (Tables)	12 Months Ended
	Jun. 30, 2018
Inventory Disclosure [Abstract]
Schedule of Inventory	June 30, June 30, 2018 2017 Work in process $ 126,047 $ – Finished goods 111,681 – Allowance for inventory obsolescence (36,039 ) – Total inventory $ 201,689 $ –

16. Property And Equipment (Tab

16. Property And Equipment (Tables)	12 Months Ended
	Jun. 30, 2018
Property, Plant and Equipment [Abstract]
Property And Equipment	June 30, 2018 2017 Property and equipment $ 1,874,480 $ – Furniture and office equipment 173,500 – Land 630,805 – Building 2,170,963 – Total fixed assets 4,849,748 – Accumulated depreciation (63,698 ) – Total fixed assets, net $ 4,786,050 $ –

1. Nature of Operations (Detail

1. Nature of Operations (Details - Fair Value) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Liabilities:
Derivative Liabilities	$ 0	$ 52,757	$ 0	$ 0
Total Financial Liabilities	0	52,757
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Liabilities:
Derivative Liabilities		0
Total Financial Liabilities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities:
Derivative Liabilities	0	0
Total Financial Liabilities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities:
Derivative Liabilities	0	52,757
Total Financial Liabilities	$ 0	$ 52,757

1. Nature of Operations (Deta_2

1. Nature of Operations (Details - Level 3 liabilities)	12 Months Ended
	Jun. 30, 2018USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Derivative liabilities, beginning balance	$ 52,757
Note inception date fair value	6,370
Change in fair value	(59,127)
Derivative liabilities, ending balance	$ 0

1. Nature of Operations (Deta_3

1. Nature of Operations (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Accounts Receivable	$ 20,261	$ 0
Obsolescence allowance	36,039	0
Advertising expense	$ 49,656	$ 41,712
Warrants [Member]
Antidilutive shares	4,518,167

2. Entry Into a Definitive Ag_2

2. Entry Into a Definitive Agreements (Details Narrative)	12 Months Ended
	Jun. 30, 2018USD ($)
Business Combinations [Abstract]
Sales or commissions earned	$ 0

3. Business Combination and Ass

3. Business Combination and Asset Acquisitions (Details) - USD ($)	6 Months Ended	10 Months Ended	11 Months Ended	12 Months Ended
	Jan. 05, 2018	Apr. 16, 2018	May 31, 2018	Jun. 30, 2018	Jun. 15, 2018	Jun. 30, 2017
Consideration given:
Cash consideration				$ 356,000		$ 0
Fair value of identifiable assets acquired, and liabilities assumed:
Goodwill				70,000		0
Investment written off				$ (12,141)		$ 0
Irie [Member]
Consideration given:
Cash consideration		$ 356,000
Common stock shares given		999,000
Notes assumed		100,000
Total consideration given		1,455,000
Fair value of identifiable assets acquired, and liabilities assumed:
Current assets		226,000
Current liabilities		44,000
Net Working Capital		182,000
Fixed assets, net		25,000
Goodwill		70,000
Total consideration		1,455,000
Irie [Member] | Customer Contracts [Member]
Fair value of identifiable assets acquired, and liabilities assumed:
Intangible assets, net		712,000
Irie [Member] | Assembled Workforce [Member]
Fair value of identifiable assets acquired, and liabilities assumed:
Intangible assets, net		139,000
Irie [Member] | Trade Names [Member]
Fair value of identifiable assets acquired, and liabilities assumed:
Intangible assets, net		$ 327,000
Greenhouse [Member]
Consideration given:
Total consideration given					$ 4,800,000
Fair value of identifiable assets acquired, and liabilities assumed:
Total consideration					$ 4,800,000
Green Market [Member]
Consideration given:
Common stock shares given	$ 295,400
Total consideration given	295,400
Fair value of identifiable assets acquired, and liabilities assumed:
Cash	3,546
Accounts receivable	7,430
Accounts payable	(71,478)
Acquisition payable	(24,805)
Payable to shareholders	(5,045)
Fixed assets, net	64,891
Intangible assets, net	5,176
Total identifiable net liabilities	(20,285)
Goodwill	315,685
Total consideration	$ 295,400
Common stock shares returned			$ (295,400)
Investment written off			$ (33,000)

3. Business Combination and A_2

3. Business Combination and Asset Acquisitions (Details Narrative) - Valencia [Member]	12 Months Ended
	Jun. 30, 2018USD ($)
Total consideration	$ 4,800,000
Euro Member Countries, Euro
Total consideration	$ 4,000,000

4. Going Concern (Details Narra

4. Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Going Concern
Net loss attributable to common stockholders	$ (4,628,673)
Net cash used in operating activities	(1,100,802)	$ (435,450)
Working capital	1,081,685
Stockholders' equity	3,018,398	187,818	$ (284,390)
Accumulated deficit	$ (9,540,976)	$ (4,920,988)

5. Commitments and Contingenc_3

5. Commitments and Contingencies (Details)	Jun. 30, 2018USD ($)
Las Vegas [Member]
2,019	$ 29,646
Total	29,646
Irie in Oakland [Member]
2,019	40,700
Total	$ 40,700

5. Commitments and Contingenc_4

5. Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Las Vegas [Member]
Rent expense	$ 32,046	$ 39,600
Irie in Oakland [Member]
Rent expense	$ 16,564

6. Related Parties (Details Nar

6. Related Parties (Details Narrative) - USD ($)	May 10, 2018	Apr. 30, 2018	Jun. 30, 2018	Jun. 30, 2017	Nov. 15, 2019	May 15, 2018
Cowan
Due to related parties			$ 15,485	$ 269,225
Cowan | License Agreement [Member]
Cancellation of payables						$ 240,000
Warrants issued					1,000,000
Perry
Due to related parties			32,813	$ 133,944
Stock issued for compensation, shares				5,784,061
Stock issued for compensation, value				$ 112,500
Loss on settlement of liabilities				130,431
Medeiros [Member]
Due to related parties			$ 63,000	$ 52,500
Stock issued for compensation, shares				2,699,228
Stock issued for compensation, value				$ 52,500
Loss on settlement of liabilities				$ 60,368
Pelosi [Member]
Stock issued for compensation, shares			850,000
Proceeds from sale of stock			$ 14,500
Pelosi [Member] | Pelosi Sale [Member]
Stock issued for cash, shares			967,000
Proceeds from sale of stock			$ 14,500
Stock date of sale			Nov. 10, 2017
Pelosi [Member] | Pelosi Sale 2 [Member]
Stock issued for cash, shares			1,050,000
Proceeds from sale of stock			$ 21,000
Stock date of sale			Jan. 18, 2018
Pelosi [Member] | Pelosi Sale 3 [Member]
Stock issued for cash, shares			2,200,000
Proceeds from sale of stock			$ 38,500
Stock date of sale			Jul. 27, 2018
Groberg [Member]
Stock issued for compensation, shares			1,400,000
Stock issued for compensation, value			$ 142,100
Stock issued for cash, shares	312,500
Segerblom [Member]
Warrants issued			500,000
Stock issued for compensation, shares			314,465
Stock issued for compensation, value			$ 50,000
Stock issued for cash, shares		314,465

7. Convertible Notes Payable,_3

7. Convertible Notes Payable, Net of Premiums and Notes Payable (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Baytown Holdings [Member]
Principal	$ 95,000	$ 0
Debt discounts	0	0
Principal, net of discounts	95,000	0
Valencia [Member]
Principal	4,629,486	0
Debt discounts	0	0
Principal, net of discounts	4,629,486	0
Irie [Member]
Principal	99,000	0
Debt discounts	0	0
Principal, net of discounts	99,000	0
Pure Energy 1 [Member]
Principal	0	15,475
Debt discounts	0	(7,489)
Principal, net of discounts	0	7,986
Pure Energy 2 [Member]
Principal	0	13,480
Debt discounts	0	(5,565)
Principal, net of discounts	0	7,915
Power Up [Member]
Principal	0	38,000
Debt discounts	0	(18,893)
Principal, net of discounts	0	19,107
Power Up 1 [Member]
Principal	0	75,000
Debt discounts	0	(39,330)
Principal, net of discounts	0	35,670
Convertible Notes Payable [Member]
Principal	4,832,486	141,955
Debt discounts	0	(71,277)
Principal, net of discounts	$ 4,832,486	$ 70,678

7. Convertible Notes Payable,_4

7. Convertible Notes Payable, Net of Premiums and Notes Payable (Details Narrative) - USD ($)	1 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Jan. 26, 2018	Jul. 19, 2017	Jun. 19, 2017	Dec. 31, 2017	Mar. 31, 2018	Jun. 30, 2018	Jun. 30, 2017
Beneficial conversion feature						$ (45,416)	$ (79,156)
Amortization of beneficial conversion feature						$ 187,902	$ 0
Pure Energy [Member]
Conversion of debt, stock issued						5,764,490
Conversion of debt, debt converted						$ 80,077
Convertible Debt [Member] | Perlowin [Member]
Debt issuance date						Jul. 7, 2015
Debt face value						$ 5,000
Debt interest rate						12.00%
Convertible rate						10.00%
Beneficial conversion feature						$ 5,000
Amortization of beneficial conversion feature						5,000
Accrued interest						$ 467
Stock issued on conversion of debt, shares issued						50,000
Stock issued on conversion of debt, debt converted						$ 5,000
Convertible Debt [Member] | Ogorodnikova [Member]
Debt issuance date						Aug. 20, 2015
Debt face value						$ 12,500
Debt interest rate						12.00%
Convertible rate						10.00%
Beneficial conversion feature						$ 12,500
Amortization of beneficial conversion feature						12,500
Accrued interest						$ 986
Stock issued on conversion of debt, shares issued						125,000
Stock issued on conversion of debt, debt converted						$ 12,500
Convertible Debt [Member] | Eagle Equities [Member]
Debt issuance date						Nov. 1, 2016
Debt face value						$ 25,000
Debt interest rate						8.00%
Proceeds from convertible note						$ 23,000
Payment of debt issuance fees						2,000
Debt discount				$ 25,000
Amortization of debt discount				$ 25,000
Accrued interest						$ 0
Debt maturity date						Nov. 1, 2017
Convertible Debt [Member] | Pure Energy [Member]
Debt issuance date						May 23, 2017
Debt face value						$ 15,475
Debt interest rate						8.00%
Proceeds from convertible note						$ 15,475
Debt discount						$ 8,481
Debt maturity date						Feb. 23, 2018
Conversion of debt, stock issued	1,933,848	748,934	791,140			1,006,768
Conversion of debt, debt converted	$ 33,842	$ 13,481	$ 12,501
Convertible Debt [Member] | Power Up [Member]
Debt issuance date						May 10, 2017
Debt face value						$ 75,000
Debt interest rate						8.00%
Proceeds from convertible note						$ 78,427
Debt maturity date						Feb. 23, 2018
Convertible Debt [Member] | Power Up [Member]
Debt issuance date						Jun. 20, 2017
Debt face value						$ 38,000
Debt interest rate						8.00%
Proceeds from convertible note						$ 38,000
Debt discount						19,611
Amortization of debt discount						$ 6,609
Debt maturity date						Feb. 23, 2018
Convertible Debt [Member] | Power Up [Member]
Debt issuance date						Jul. 20, 2017
Debt face value						$ 38,000
Debt interest rate						8.00%
Proceeds from convertible note						$ 38,000
Debt discount					$ 14,829
Amortization of debt discount					7,455
Accrued interest					$ 0	$ 2,175
Debt maturity date						Aug. 11, 2018
Stock issued on conversion of debt, shares issued						800,918
Stock issued on conversion of debt, debt converted						$ 22,826
Conversion of debt, stock issued						2,008,740
Conversion of debt, debt converted						$ 40,175
Convertible Debt [Member] | LG Capital [Member]
Debt issuance date						Aug. 11, 2017
Debt face value						$ 42,000
Accrued interest						1,565
Repayment of convertible note						58,813
Prepayment penaly and legal fees						$ 15,248
Convertible Debt [Member] | Power Up [Member]
Debt issuance date						Sep. 26, 2017
Debt face value						$ 53,000
Repayment of convertible note						$ 71,913
Convertible Debt [Member] | Pure Energy [Member]
Debt issuance date						Sep. 27, 2017
Debt face value						$ 78,427
Repayment of convertible note						$ 33,842
Conversion of debt, stock issued	1,933,848					5,765,490
Conversion of debt, debt converted	$ 33,842					$ 28,496
Prepayment penaly and legal fees						$ 5,346
Convertible Debt 2 [Member] | Perlowin [Member]
Debt issuance date						Aug. 12, 2015
Debt face value						$ 5,000
Debt interest rate						12.00%
Convertible rate						10.00%
Beneficial conversion feature						$ 5,000
Amortization of beneficial conversion feature						5,000
Accrued interest						$ 408
Stock issued on conversion of debt, shares issued						50,000
Stock issued on conversion of debt, debt converted						$ 5,000
Non Convertible Debt [Member] | Baytown Holdings [Member]
Debt issuance date						Jun. 4, 2018
Debt face value						$ 95,000
Original issue discount						10,000
Proceeds from convertible note						85,000
Non Convertible Debt [Member] | Valencia [Member]
Debt face value						4,348,911
Non Convertible Debt [Member] | Irie [Member]
Debt face value						$ 93,000

8. Stockholders' Equity (Detail

8. Stockholders' Equity (Details - Warrants Granted) - Warrant [Member]	12 Months Ended
	Jun. 30, 2018$ / sharesshares
Warrants
Warrants Outstanding, beginning balance	4,618,167
Warrants Granted	7,694,444
Warrants Exercised	(268,167)
Warrants Cancelled	(3,250,000)
Warrants Outstanding, ending balance	8,794,444
Warrants Exercisable	7,794,444
Weighted Average Exercise Price
Weighted average exercise price, warrants Granted | $ / shares	$ 0.13
Weighted average exercise price, warrants Exercised | $ / shares	0.06
Weighted average exercise price, warrants Cancelled | $ / shares	0.05
Weighted average exercise price, warrants Outstanding, ending price | $ / shares	0.12
Weighted average exercise price, warrants Exercisable | $ / shares	$ 0.10
Weighted Average Remaining Contractual Life
Weighted average remaining contractual life	1 year 6 months 10 days
Weighted average remaining contractual life, warrants Exercisable	1 year 8 months 23 days

8. Stockholders' Equity (Deta_2

8. Stockholders' Equity (Details - Warrants outstanding )	12 Months Ended
	Jun. 30, 2018$ / sharesshares
$0.01 - $0.09 [Member]
Number Outstanding	2,200,000
Weighted-Average Remaining Contractual Life	1 year 10 months 21 days
Number Exercisable	2,200,000
Weighted-Average Exercise Price | $ / shares	$ 0.05
$0.01 - $0.09 [Member]
Number Outstanding	5,594,444
Weighted-Average Remaining Contractual Life	1 year 7 months 28 days
Number Exercisable	5,594,444
Weighted-Average Exercise Price | $ / shares	$ 0.12
$0.01 - $0.09 [Member]
Number Outstanding	1,000,000
Weighted-Average Remaining Contractual Life	0 years
Number Exercisable
Weighted-Average Exercise Price | $ / shares
$0.01 - $0.29 [Member]
Number Outstanding	8,794,444
Weighted-Average Remaining Contractual Life	1 year 6 months 10 days
Number Exercisable	7,794,444
Weighted-Average Exercise Price | $ / shares	$ 0.10

8. Stockholders' Equity (Deta_3

8. Stockholders' Equity (Details Narrative) - USD ($)

Jun. 11, 2018

Jun. 01, 2018

May 14, 2018

May 10, 2018

Apr. 11, 2018

Apr. 03, 2018

Apr. 02, 2018

May 25, 2016

Jun. 21, 2018

Apr. 30, 2018

Mar. 31, 2018

Jun. 30, 2018

Jun. 30, 2017

Nov. 15, 2019

May 15, 2018

Common stock issued

185,369,365

111,101,795

Common stock outstanding

185,369,365

111,101,795

Stock issued during the period, value

$ 851,058

$ 150,000

Stock issued for services, value

1,339,715

$ 750,990

Stock issued for acquisition, Value

$ 1,294,023

The Company [Member]

Common stock issuable

1,793,195

2016 Stock Option Plan [Member]

Shares reserved under plan

10,000,000

Pelosi [Member]

Common stock issued for warrants

1,250,000

Warrants Expire Date

Aug. 11, 2018

Stock issued for compensation, shares issued

850,000

Sale of common stock, shares

967,000

Sale of common stock, value

$ 14,500

Common stock issued for option

$ 1,250,000

Stock issued for acquisition, Shares

1,050,000

Stock issued for acquisition, Value

$ 21,000

Perry

Number of common stock converted

68,401,200

Conversion of common stock into Series A preferred stock

684,012

Stock issued for compensation, shares issued

5,784,061

Cowan

Number of common stock converted

26,401,000

Conversion of common stock into Series A preferred stock

264,010

Cowan | License Agreement [Member]

Common stock issued for warrants

1,000,000

Warrants exercise price

$ 0.01

Cancellation of payables

$ 240,000

JRKH Investments [Member]

Stock issued during the period, shares issued

54,745

Stock issued during the period, value

$ 5,000

KSW Group [Member]

Stock issued during the period, shares issued

450,000

Esteemed Consultants [Member]

Stock issued for acquisition, Shares

1,000,000

Stock issued for acquisition, Value

$ 75,000

Kahn Family Partnership [Member]

Stock issued during the period, shares issued

4,444,444

Stock issued during the period, value

$ 400,000

Common stock issued for warrants

4,444,444

Warrants exercise price

$ 0.13

Warrants Expire Date

Apr. 11, 2020

Segerblom [Member]

Stock issued during the period, shares issued

314,465

Stock issued during the period, value

$ 50,000

Common stock issued for warrants

500,000

Warrants exercise price

$ 0.10

Stock Vesting period

1 year

Warrants Vesting period

18 months

Stock issued for compensation, shares issued

314,465

Groberg [Member]

Stock issued during the period, shares issued

312,500

Stock issued during the period, value

$ 50,000

Common stock issued for warrants

500,000

Warrants exercise price

$ 0.10

Stock Vesting period

1 year

Warrants Vesting period

18 months

Stock issued for compensation, shares issued

1,400,000

Caesar Capital Group [Member]

Stock issued during the period, shares issued

1,250,000

JosephWAndPatriciaGAbramsFamilyTrust [Member]

Stock issued during the period, shares issued

1,250,000

Abrams [Member]

Stock issued during the period, shares issued

2,500,000

Stock issued during the period, value

$ 200,000

Stock issued for services, shares issued

312,500

Stock issued for services, value

$ 54,844

Abrams [Member]

Stock issued during the period, shares issued

6,000,000

1,600,000

Stock issued during the period, value

$ 995,400

GMEs sellers [Member] | Termination Agreement [Member]

Common stock cancelled

4,220,000

Kahn Family Trust [Member]

Stock issued for services, shares issued

160,000

Stock issued for services, value

$ 27,008

Harvey Katz [Member]

Stock issued for services, shares issued

50,000

Stock issued for services, value

$ 8,440

Warm Family Revocable Trust [Member]

Stock issued for services, shares issued

50,000

Stock issued for services, value

$ 8,440

The Allan S. Kaplan Revocable Trust [Member]

Stock issued for services, shares issued

50,000

Stock issued for services, value

$ 8,440

Marianne Luzzo [Member]

Stock issued during the period, shares issued

64,300

Stock issued for compensation, shares issued

15,125

Stock issued for compensation, value

$ 2,042

Silkia Ostrander [Member]

Stock issued during the period, shares issued

53,684

Stock issued for compensation, shares issued

38,050

Stock issued for compensation, value

$ 5,137

Enrique Sempere [Member]

Stock issued for compensation, shares issued

70,446

Stock issued for compensation, value

$ 12,500

Rodrigo Chavez [Member]

Stock issued for compensation, shares issued

500,000

Stock issued for compensation, value

$ 67,500

Ozzie Guzman [Member]

Stock issued for services, shares issued

300,000

Stock issued for services, value

$ 50,640

Trevor Hill [Member]

Stock issued for services, shares issued

16,907

Stock issued for services, value

$ 3,000

Chris Thompson [Member]

Stock issued during the period, shares issued

20,834

Stone 1 [Member]

Stock issued for services, shares issued

600,000

Lakeport Business Services [Member]

Stock issued for services, shares issued

273,333

Stock issued for services, value

$ 8,200

Stock issued for accounts payable, shares issued

345,451

Stock issued for accounts payable, amount

$ 9,450

Chris Thompson [Member]

Stock issued for services, shares issued

600,000

Stock issued for services, value

$ 48,900

Joshua Halford [Member]

Stock issued for services, shares issued

550,000

Stock issued for services, value

$ 44,825

Christopher Sloan [Member]

Stock issued for services, shares issued

1,061,500

Stock issued for services, value

$ 137,535

Stock issued for accounts payable, shares issued

400,000

Stock issued for accounts payable, amount

$ 23,075

Neil Dutson [Member]

Stock issued for services, shares issued

530,303

Stock issued for services, value

$ 37,203

Stock issued for leasehold improvement, shares issued

30,000

Stock issued for leasehold improvement, value

$ 900

Stock issued for acquisition, Shares

909,090

Stock issued for acquisition, Value

$ 100,000

Frank Dobrucki [Member]

Stock issued for services, shares issued

750,000

Stock issued for services, value

$ 48,475

Michael Ostrander [Member]

Stock issued for services, shares issued

600,000

Stock issued for services, value

$ 24,420

Timothy Puetz [Member]

Stock issued for services, shares issued

1,001,250

Stock issued for services, value

$ 30,038

Ronald Voight [Member]

Stock issued for services, shares issued

255,000

Stock issued for services, value

$ 7,650

Legal counsel [Member]

Stock issued for services, shares issued

122,500

Stock issued for services, value

$ 8,575

Victor Park [Member]

Stock issued for services, shares issued

250,000

Stock issued for services, value

$ 7,725

Stone [Member]

Common stock issuable

600,000

Stock issued for services, shares issued

600,000

Stock issued for services, value

$ 29,400

Marc Hatch [Member]

Stock issued for services, shares issued

100,000

Stock issued for services, value

$ 7,430

Jason Edwards [Member]

Stock issued for services, shares issued

400,000

Stock issued for services, value

$ 16,280

Lakeport Business Service [Member]

Stock issued for services, shares issued

83,760

Stock issued for services, value

$ 18,000

Lakeport Business Services 1 [Member]

Stock issued for services, shares issued

47,945

Stock issued for services, value

$ 15,558

ChristopherSloanMember

Stock issued for services, shares issued

122,466

Stock issued for services, value

$ 39,740

Michael Ostrander 1 [Member]

Stock issued for services, shares issued

150,000

Stock issued for services, value

$ 10,500

Michael Ostrander 2 [Member]

Stock issued for services, shares issued

56,930

Stock issued for services, value

$ 16,737

Christopher Thompson 1 [Member]

Stock issued for services, shares issued

226,497

Stock issued for services, value

$ 33,069

Legal counsel 1 [Member]

Stock issued for services, shares issued

16,952

Stock issued for services, value

$ 2,475

Steven Bloom [Member]

Stock issued for services, shares issued

82,192

Stock issued for services, value

$ 12,000

Weintraub [Member]

Common stock issued for warrants

268,167

Number of warrants surrendered

52,779

Proceeds from warrants surrendered

$ 16,090

Acquisition of cashless exercise of warrants, Shares

215,378

Stock issued for settlement of payables, value

$ 15,065

Cliff Perry [Member]

Stock issued for compensation, shares issued

5,784,061

Stock issued for compensation, value

$ 112,500

Raymond Medeiros [Member]

Stock issued for compensation, shares issued

2,699,228

Stock issued for compensation, value

$ 52,500

Pure Energy [Member]

Debt converted, shares issued

5,764,490

Debt converted, debt amount

$ 80,077

Sale of common stock, shares

4,785,459

Sale of common stock, value

$ 83,746

Stock issued for acquisition, Shares

526,315

Stock issued for acquisition, Value

$ 25,000

Stock isued for convertible promissory note, Shares

1,933,848

Stock isued for convertible promissory note, Value

$ 33,842

Common stock received

580,154

Loss on issue of convertible note

$ (558,722)

Reliable Steel [Member]

Debt converted, shares issued

229,671

Debt converted, debt amount

$ 33,532

Nuaxon Bioscience [Member]

Stock issued for licensing rights, shares

500,000

Stock issued for licensing rights, value

$ 22,000

Breadfruit Tree Inc [Member]

Stock issued for inventory received, shares issued

1,000,000

Stock issued for inventory received value

$ 27,200

GME’s seller [Member]

Stock issued for acquisition, Shares

4,220,000

Stock issued for acquisition, Value

$ 295,400

Vision Concepts [Member]

Stock issued for acquisition, Shares

74,074

Stock issued for acquisition, Value

$ 10,000

Rex Anthony Carrol [Member]

Stock issued for acquisition, Shares

272,727

Stock issued for acquisition, Value

$ 30,000

Esteemed Consultants [Member]

Stock issued for acquisition, Shares

909,091

Stock issued for acquisition, Value

$ 100,000

Moreno [Member]

Stock issued for acquisition, Shares

500,000

Stock issued for acquisition, Value

$ 50,000

Douglas Montgomery [Member]

Stock issued for acquisition, Shares

160,000

Greg Montgomery [Member]

Stock issued for acquisition, Shares

80,000

Lesley Montgomery [Member]

Stock issued for acquisition, Shares

160,000

Neil Dutson 1 [Member]

Stock issued for acquisition, Shares

624,000

Stock issued for acquisition, Value

$ 78,000

Pure Energy 1 [Member]

Stock issued for acquisition, Shares

838,126

Stock issued for acquisition, Value

$ 83,813

Stock isued for convertible promissory note, Shares

800,918

Stock isued for convertible promissory note, Value

$ 22,826

Common stock received

89,703

Loss on issue of convertible note

$ (66,877)

Joseph Gurreri [Member]

Common stock issued in consideration of accrued wages, Shares

60,616

Common stock issued in consideration of accrued wages, value

$ 8,550

Groberg [Member]

Stockholders' Equity Description

On January 18, 2018, in connection with the Company’s appointment of Richard Groberg (“Groberg”) as its Chief Financial Officer to serve for an initial, two-year term, the Company (i) issued Groberg’s company, RSGroberg Consulting, LLC, 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. The common stock received was valued at $81,200 and $60,900, respectively.</p>" id="sjs-M253">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 18, 2018, in connection with the Company&#8217;s appointment of Richard Groberg (&#8220;Groberg&#8221;) as its Chief Financial Officer to serve for an initial, two-year term, the Company (i) issued Groberg&#8217;s company, RSGroberg Consulting, LLC, 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months&#8217; compensation), and (2) payable in cash thereafter. The common stock received was valued at $81,200 and $60,900, respectively.&lt;/p>

Pure Energy 2 [Member]

Stock isued for convertible promissory note, Shares

2,008,740

Stock isued for convertible promissory note, Value

$ 40,175

Common stock received

190,027

Loss on issue of convertible note

$ (157,340)

Valencia [Member]

Common stock issuable

4,142,857

Contingent liability

$ 174,000

Rene Velez [Member]

Stock issued during the period, shares issued

177,032

Jason Edwards [Member]

Stock issued during the period, shares issued

200,000

Michael Ostrander [Member]

Stock issued during the period, shares issued

596,163

Jason Edwards [Member]

Stock issued during the period, shares issued

400,000

consultant [Member]

Stock issued during the period, shares issued

120,000

Michael Ostrander [Member]

Stock issued during the period, shares issued

300,000

Karen Lane [Member]

Stock issued during the period, shares issued

67,545

Ricky Potts [Member]

Stock issued during the period, shares issued

67,545

9. Revenue Classes (Details)

9. Revenue Classes (Details) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Revenues	$ 411,272	$ 817,457
Cost of revenues	311,213	124,290
Magazine related [Member]
Revenues	9,484	39,161
Cost of revenues	89,518	124,290
Referral Fees [Member]
Revenues	0	10,054
Cost of revenues	0	0
Licensing Fees [Member]
Revenues	0	750,000
Cost of revenues	0	0
Product sales [Member]
Revenues	401,788	0
Cost of revenues	211,695	0
Equipment sales commissions [Member]
Revenues	0	18,242
Cost of revenues	$ 0	$ 0

10. Income Tax (Details - Tax e

10. Income Tax (Details - Tax expense) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Tax expense (benefit) at the statutory rate	$ 972,021	$ (309,621)
State income taxes, net of federal income tax benefit	0	(134)
Change in valuation allowance	(972,021)	309,755
Total	$ 0	$ 0

10. Income Tax (Details - Defer

10. Income Tax (Details - Deferred tax assets) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Deferred tax assets:
Net operating loss carryforward	$ 1,398,216	$ 1,073,183
Timing differences	906,968	908,366
Total gross deferred tax assets	2,305,184	1,981,549
Less: Deferred tax asset valuation allowance	(2,305,184)	(1,981,549)
Total net deferred tax assets	$ 0	$ 0

10. Income Tax (Details Narrati

10. Income Tax (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 4,661,920	$ 3,196,453
Loss carryforward expiration date	Dec. 31, 2038
Federal income tax rate	21.00%	34.00%

11. Concentrations (Details Nar

11. Concentrations (Details Narrative)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Revenues [Member]
Concentration risk percentage	64.90%	90.30%

13. Intangible Assets (Details

13. Intangible Assets (Details - Intangible assets) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Intangible assets, gross	$ 1,838,765	$ 12,245
Less: Accumulated amortization	(316,191)	(1,425)
Intangible assets, net	1,522,574	10,820
Websites and other intangible assets [Member]
Intangible assets, gross	519,923	12,245
Trademarks and Trade Names [Member]
Intangible assets, gross	342,682	0
Customer Relationships [Member]
Intangible assets, gross	712,000	0
Patents and intellectual property [Member]
Intangible assets, gross	$ 264,160	$ 0

13. Intangible Assets (Detail_2

13. Intangible Assets (Details - Amortization) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
2,018	$ 691,788
2,019	477,884
2,020	148,603
2,021	89,165
2022 and thereafter	115,134
Total	$ 1,522,574	$ 10,820

13. Intangible Assets (Detail_3

13. Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 332,964	$ 741

14. Derivatives (Details - Assu

14. Derivatives (Details - Assumptions) - Embedded Derivative Financial Instruments [Member]	9 Months Ended
	Mar. 31, 2018
Note Inception Date [Member] | Measurement Input, Option Volatility [Member]
Assumptions	170% - 232%
Note Inception Date [Member] | Measurement Input, Expected Term [Member]
Assumptions	0.75 - 0.83 years
Note Inception Date [Member] | Measurement Input Risk Free Interest Rate [Member]
Assumptions	1.07% - 1.18%
June 2018 [Member] | Measurement Input, Option Volatility [Member]
Assumptions	0%
June 2018 [Member] | Measurement Input, Expected Term [Member]
Assumptions	0 years
June 2018 [Member] | Measurement Input Risk Free Interest Rate [Member]
Assumptions	0.00%

14. Derivatives (Details)

14. Derivatives (Details) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative liabilities, beginning balance	$ 52,757	$ 0	$ 0
Note inception date fair value allocated to debt discount	118,228	163,000	122,500
Note modifications adjustment		(54,927)
Change in fair value	(170,985)	(55,316)	(122,500)
Derivative liabilities, ending balance	$ 0	$ 52,757	$ 0

15. Inventory (Details)

15. Inventory (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Inventory Disclosure [Abstract]
Work in process	$ 126,047	$ 0
Finished goods	111,681	0
Allowance for inventory obsolescence	(36,039)	0
Total inventory	$ 201,689	$ 0

16. Property And Equipment (Det

16. Property And Equipment (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Total fixed assets	$ 4,849,748	$ 0
Accumulated depreciation	(63,698)	0
Total fixed assets, net	4,786,050	0
Property, Plant and Equipment [Member]
Total fixed assets	1,874,480	0
Furniture and office equipment [Member]
Total fixed assets	173,500	0
Land [Member]
Total fixed assets	630,805	0
Building [Member]
Total fixed assets	$ 2,170,963	$ 0

16. Property And Equipment (D_2

16. Property And Equipment (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 63,698	$ 0

17. Investments (Details Narrat

17. Investments (Details Narrative) - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Investments	$ 995,400	$ 0
Cicero Transact Group [Member]
Investment, Ownership Percentage	25.00%